<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002114" GROUP_ID="INCONT" ID="534099092009443289" MERGED_FROM="" MODIFIED="2013-07-08 11:20:10 +0100" MODIFIED_BY="Muhammad Imran Omar" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Short title (no longer in use): Vaginal cones for stress incontinence&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2013-07-08 11:18:18 +0100" NOTES_MODIFIED_BY="Muhammad Imran Omar" REVIEW_NO="011" REVMAN_SUB_VERSION="5.2.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2013-07-08 11:20:10 +0100" MODIFIED_BY="Muhammad Imran Omar">
<TITLE>Weighted vaginal cones for urinary incontinence</TITLE>
<CONTACT MODIFIED="2013-07-08 11:20:10 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="4695" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Peter</FIRST_NAME><LAST_NAME>Herbison</LAST_NAME><POSITION>Statistician</POSITION><EMAIL_1>peter.herbison@otago.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Preventive &amp; Social Medicine</DEPARTMENT><ORGANISATION>Dunedin School of Medicine, University of Otago</ORGANISATION><ADDRESS_2>PO Box 913</ADDRESS_2><CITY>Dunedin</CITY><ZIP>9054</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 3 4797217</PHONE_1><FAX_1>+64 3 4797298</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-07-08 11:20:10 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="4695" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Peter</FIRST_NAME><LAST_NAME>Herbison</LAST_NAME><POSITION>Statistician</POSITION><EMAIL_1>peter.herbison@otago.ac.nz</EMAIL_1><ADDRESS><DEPARTMENT>Department of Preventive &amp; Social Medicine</DEPARTMENT><ORGANISATION>Dunedin School of Medicine, University of Otago</ORGANISATION><ADDRESS_2>PO Box 913</ADDRESS_2><CITY>Dunedin</CITY><ZIP>9054</ZIP><COUNTRY CODE="NZ">New Zealand</COUNTRY><PHONE_1>+64 3 4797217</PHONE_1><FAX_1>+64 3 4797298</FAX_1></ADDRESS></PERSON><PERSON ID="8C9000B682E26AA201BA4B54CCDBD78B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Nicola</FIRST_NAME><LAST_NAME>Dean</LAST_NAME><POSITION>Consultant Obstetrician and Gynaecologist</POSITION><EMAIL_1>nicola.dean@york.nhs.uk</EMAIL_1><EMAIL_2>nicoladean05@yahoo.co.uk</EMAIL_2><ADDRESS><DEPARTMENT>Obstetrics &amp; Gynaecology</DEPARTMENT><ORGANISATION>York Hospitals NHS Foundation Trust</ORGANISATION><ADDRESS_1>Wigginton Road</ADDRESS_1><CITY>York</CITY><ZIP>YO31 8HE</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1904 631313</PHONE_1><PHONE_2>+44 1904 726880</PHONE_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-05-14 09:56:33 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="4" MONTH="3" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="3" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="3" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2002"/>
</DATES>
<WHATS_NEW MODIFIED="2013-06-13 13:38:39 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-13 13:38:39 +0100" MODIFIED_BY="G Peter Herbison">
<DATE DAY="14" MONTH="5" YEAR="2013"/>
<DESCRIPTION>
<P>Six new trials added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-05-14 09:57:47 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="5" YEAR="2013"/>
<DESCRIPTION>
<P>Six new trials added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-05-14 09:57:11 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-05-14 09:57:11 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 15:52:40 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>Updated Issue 1, 2008<BR/>McGrouther et al has been removed from the pending studies as it has now been published as Williams 2006 and is included. Williams 2005 is excluded as it does not report on cone therapy. Jill Mantle is no longer an author as she has now retired completely.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 16:03:14 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="2" YEAR="2006"/>
<DESCRIPTION>
<P>Updated Issue 2, 2006<BR/>The third update of the review (Dec 2005) includes the following:<BR/>The authorship has changed. Stan Plevnik is no longer an author. Nicola Dean has been added to the authors.<BR/>One extra study has been added to the excluded studies list (Parkkinen 2004), and one to the included studies (Seo 2004). This has not changed the conclusions at all.<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 16:10:07 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="8" YEAR="2003"/>
<DESCRIPTION>
<P>Issue 4 2003 Search updated July 2003: no new eligible studies found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-29 16:16:34 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="11" YEAR="2002"/>
<DESCRIPTION>
<P>Updated Issue 1, 2002<BR/>This updated review includes the results of five extra studies, three new ones (Arvonen 2001; Delneri 2000; Laycock 2001) and two abstracts from conference proceedings that have only been identified since the review was first written (Bourcier 1994; Burton 1993). These studies did not change the conclusions for several reasons. Some evaluated new comparisons, most were small, and inadequate reporting meant that some outcomes could not be used.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="30" MONTH="8" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-05-14 10:01:25 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Dunedin Faculty of Medicine</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2013-05-14 10:01:25 +0100" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>Southern Regional Health Authority</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>New Zealand Health Research Council</NAME>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-05-14 10:01:25 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Incontinence Group. </P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-07-08 11:15:56 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-06-18 13:03:42 +0100" MODIFIED_BY="G Peter Herbison">
<TITLE>Vaginal weights for training the pelvic floor muscles to treat urinary incontinence in women</TITLE>
<SUMMARY_BODY MODIFIED="2013-06-18 13:03:42 +0100" MODIFIED_BY="G Peter Herbison">
<P>Leaking urine when coughing, sneezing, or exercising (stress urinary incontinence) is a common problem for women. This is especially so after giving birth, when about one woman in three will leak urine. Training of the pelvic floor muscles is the most common form of treatment for this problem. One way that women can train these muscles is by inserting cone-shaped weights into the vagina, and then contracting the pelvic floor muscles to stop the weights from slipping out again.</P>
<P>Twenty-three small trials, involving 1806 women, were found. The results of these trials consistently showed that the use of vaginal weights is better than having no treatment. When vaginal weights were compared to other treatments, such as pelvic floor muscle training without the weights, and electrical stimulation of the pelvic floor, no clear differences between the treatments were evident. This may have been because the numbers of participants in the trials were small, and larger numbers may be required for any differences in the effectiveness of treatments to become clear.</P>
<P>Some women find vaginal weights unpleasant or difficult to use, so this treatment may not be useful for all women.</P>
<P>Many women with stress urinary incontinence will not be cured by these treatments, and so it is important for trials to assess quality of life during and after treatment, but few of these trials did. Most of the trials were of fairly short duration, so it is difficult to say what happens to women with stress urinary incontinence in the longer term.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-07-08 11:10:34 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-06-18 13:02:46 +0100" MODIFIED_BY="[Empty name]">
<P>For a long time pelvic floor muscle training (PFMT) has been the most common form of conservative (non-surgical) treatment for stress urinary incontinence (SUI). Weighted vaginal cones can be used to help women to train their pelvic floor muscles. Cones are inserted into the vagina and the pelvic floor is contracted to prevent them from slipping out.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-07-08 11:10:34 +0100" MODIFIED_BY="[Empty name]">
<P>The objective of this review is to determine the effectiveness of vaginal cones in the management of female urinary stress incontinence (SUI).</P>
<P>We wished to test the following comparisons in the management of stress incontinence:<BR/>1. vaginal cones versus no treatment;<BR/>2. vaginal cones versus other conservative therapies, such as PFMT and electrostimulation;<BR/>3. combining vaginal cones and another conservative therapy versus another conservative therapy alone or cones alone;<BR/>4. vaginal cones versus non-conservative methods, for example surgery or injectables.</P>
<P>Secondary issues which were considered included whether:<BR/>1. it takes less time to teach women to use cones than it does to teach the pelvic floor exercise;<BR/>2. self-taught use is effective;<BR/>3. the change in weight of the heaviest cone that can be retained is related to the level of improvement;<BR/>4. subgroups of women for whom cone use may be particularly effective can be identified.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-06-18 13:05:49 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Incontinence Group Specialised Trials Register (searched 19 September 2012), MEDLINE (January 1966 to March 2013), EMBASE (January 1988 to March 2013) and reference lists of relevant articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised or quasi-randomised controlled trials comparing weighted vaginal cones with alternative treatments or no treatment.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-06-18 13:03:11 +0100" MODIFIED_BY="G Peter Herbison">
<P>Two reviewers independently assessed studies for inclusion and trial quality. Data were extracted by one reviewer and cross-checked by the other. Study authors were contacted for extra information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-06-18 13:03:39 +0100" MODIFIED_BY="[Empty name]">
<P>We included 23 trials involving 1806 women, of whom 717 received cones. All of the trials were small, and in many the quality was hard to judge. Outcome measures differed between trials, making the results difficult to combine. Some trials reported high drop-out rates with both cone and comparison treatments. Seven trials were published only as abstracts.</P>
<P>Cones were better than no active treatment (rate ratio (RR) for failure to cure incontinence 0.84, 95% confidence interval (CI) 0.76 to 0.94). There was little evidence of difference for a subjective cure between cones and PFMT (RR 1.01, 95% CI 0.91 to 1.13), or between cones and electrostimulation (RR 1.26, 95% CI 0.85 to 1.87), but the confidence intervals were wide. There was not enough evidence to show that cones plus PFMT was different to either cones alone or PFMT alone. Only seven trials used a quality of life measures and no study looked at economic outcomes.</P>
<P>Seven of the trials recruited women with symptoms of incontinence, while the others required women with urodynamic stress incontinence, apart from one where the inclusion criteria were uncertain.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-05-07 04:48:55 +0100" MODIFIED_BY="[Empty name]">
<P>This review provides some evidence that weighted vaginal cones are better than no active treatment in women with SUI and may be of similar effectiveness to PFMT and electrostimulation. This conclusion must remain tentative until larger, high-quality trials, that use comparable and relevant outcomes, are completed. Cones could be offered as one treatment option, if women find them acceptable.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-06-18 13:17:07 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-06-18 13:04:20 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-06-18 13:03:45 +0100" MODIFIED_BY="[Empty name]">
<P>The classic symptom of stress urinary incontinence (SUI) is an involuntary loss of urine during physical exertion (e.g. coughing, laughing, sneezing, and exercise) (<LINK REF="REF-Abrams-1989" TYPE="REFERENCE">Abrams 1989</LINK>). There are a variety of predisposing factors for SUI, which include pregnancy and vaginal delivery (<LINK REF="REF-Wilson-1996" TYPE="REFERENCE">Wilson 1996</LINK>), obesity (<LINK REF="REF-Bump-1992a" TYPE="REFERENCE">Bump 1992a</LINK>; <LINK REF="REF-Wilson-1996" TYPE="REFERENCE">Wilson 1996</LINK>), and cigarette smoking (<LINK REF="REF-Bump-1992b" TYPE="REFERENCE">Bump 1992b</LINK>). The strong causal link between childbearing and SUI means that it is a common problem in adult women with reported prevalences of 17% to 45% (<LINK REF="REF-Jolleys-1988" TYPE="REFERENCE">Jolleys 1988</LINK>).</P>
<P>The impact of incontinence on quality of life can be considerable for sufferers, with many reporting effects on their social, domestic, physical, occupational and leisure activities (<LINK REF="REF-Wyman-1990" TYPE="REFERENCE">Wyman 1990</LINK>). Apart from the personal and social cost to sufferers, the direct and indirect healthcare costs are substantial (<LINK REF="REF-Hu-1990" TYPE="REFERENCE">Hu 1990</LINK>).</P>
<P>Normally the bladder and urethra are supported within the pelvic cavity by ligamentous and fascial attachments, and the levator ani (a pelvic floor muscle) (<LINK REF="REF-Morley-1995" TYPE="REFERENCE">Morley 1995</LINK>). Descent of the bladder and urethra have been observed in stress incontinent women (<LINK REF="REF-Hanzal-1993" TYPE="REFERENCE">Hanzal 1993</LINK>), and it is believed that this hypermobility results from a lack of ligamentous and fascial support. In addition, denervation injuries of the levator ani during vaginal delivery may contribute to changes in position of the bladder and urethra, and a reduction in the sphincteric function about the urethra, as the muscle that keeps the bladder closed is weakened (<LINK REF="REF-Smith-1989a" TYPE="REFERENCE">Smith 1989a</LINK>; <LINK REF="REF-Smith-1989b" TYPE="REFERENCE">Smith 1989b</LINK>; <LINK REF="REF-Snooks-1984" TYPE="REFERENCE">Snooks 1984</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-06-18 13:03:58 +0100" MODIFIED_BY="[Empty name]">
<P>Pelvic floor muscle training (PFMT) is the mainstay of conservative (non-surgical) treatment for stress incontinence. This is based on the premise that identification or strength training, or both, of the pelvic floor muscles will counteract weakness by increasing support for the urethra and bladder, and improve the muscle's sphincteric action around the urethra. It has been shown that women with mild or moderate SUI may improve their ability to hold urine significantly simply by learning how to control the pelvic floor muscle strength that they already have (<LINK REF="REF-Miller-1996" TYPE="REFERENCE">Miller 1996</LINK>). Such improvement usually occurs much more quickly (one week) than the time needed to build up pelvic floor muscle strength (months).</P>
<P>Some women, however, have trouble identifying their pelvic floor muscles, and compliance with PFMT is variable (<LINK REF="REF-Kegel-1951" TYPE="REFERENCE">Kegel 1951</LINK>; <LINK REF="REF-Lagro_x002d_Janssen-1994" TYPE="REFERENCE">Lagro-Janssen 1994</LINK>; <LINK REF="REF-Walters-1992" TYPE="REFERENCE">Walters 1992</LINK>). In addition, incorrect pelvic floor muscle contractions can make the incontinence worse (<LINK REF="REF-Bump-1991" TYPE="REFERENCE">Bump 1991</LINK>). For these reasons, there have been attempts to make it easier for women to train their pelvic floor muscles. One of these methods is to use a set of graded weighted vaginal cones (<LINK REF="REF-Peattie-1988b" TYPE="REFERENCE">Peattie 1988b</LINK>; <LINK REF="REF-Plevnik-1985" TYPE="REFERENCE">Plevnik 1985</LINK>). Theoretically, when a cone is placed in the vagina the pelvic floor muscles need to be contracted to prevent the cone slipping out.</P>
<P>Women are instructed to insert the heaviest cone they can retain while standing and moving around and coughing in an upright position, and, when successful with this, they are asked to try with the next heaviest cone. Generally the instructions are to carry the cone for two sessions of 15 minutes per day, for one month or more.</P>
</INTERVENTION>
<THEORY MODIFIED="2013-06-18 13:04:07 +0100" MODIFIED_BY="[Empty name]">
<P>The perceived advantages of the cones over traditional methods of training the pelvic floor muscles include:<BR/>1. the exercise is individualised for each woman;<BR/>2. less time is needed to teach women to use the cones than to teach pelvic floor muscle training;<BR/>3. it doesn't take much time to insert and remove cones;<BR/>4. usually only one consultation is needed;<BR/>5. the cones provide a form of biofeedback as the sensation of one slipping out induces a pelvic floor muscle contraction which may both strengthen muscles and help to synchronize muscle contraction with increases in abdominal pressure (<LINK REF="REF-Deindl-1995" TYPE="REFERENCE">Deindl 1995</LINK>);<BR/>6. the graded increases in cone weight represent improvement in muscle strength and motivates women to continue;<BR/>7. the use of vaginal cones can be self-taught, and they can be used without supervision and vaginal examination (<LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>);<BR/>8. cones can be used in self-instruction of conventional PFMT (<LINK REF="REF-Peattie-1988b" TYPE="REFERENCE">Peattie 1988b</LINK>).</P>
<P>There are, however, theoretical problems with cones. It may not be the contraction of the pelvic floor muscles only that keeps the cones in place (<LINK REF="REF-B_x00f8_-1995" TYPE="REFERENCE">Bø 1995</LINK>). The vagina is not a vertical cylinder, so natural pelvic tilt may help to retain cones, and, indeed, the transverse lie of some cones has been confirmed radiographically (<LINK REF="REF-Hahn-1996" TYPE="REFERENCE">Hahn 1996</LINK>). Cones may still train the pelvic floor muscles, but the actual force that needs to be balanced by a pelvic floor muscle contraction will depend upon the angle of an individual's vagina. Thus the weight of cone that is able to be retained may not be a good measurement of pelvic floor muscle strength. Holding a cone in place may well not generate multiple contractions of the pelvic floor muscles, and thus may not be the best option for increasing their strength. Also, physically it is not possible for some women to use cones - for reasons such as having a narrowed, scarred vagina. Their effectiveness is likely to vary depending on, for example, motivation and initial pelvic floor muscle strength (with those having low strength having the most to gain) as well as individual acceptability of the method.</P>
</THEORY>
<IMPORTANCE MODIFIED="2013-06-18 13:04:20 +0100" MODIFIED_BY="[Empty name]">
<P>At the moment there is uncertainty about the best way of treating SUI, so there is a need for systematic reviews examining different treatments. This is one of several reviews looking at conservative treatment for the condition. Others look at pelvic floor muscle training (<LINK REF="REF-Dumoulin-2010" TYPE="REFERENCE">Dumoulin 2010</LINK>; <LINK REF="REF-Hay_x002d_Smith-2011" TYPE="REFERENCE">Hay-Smith 2011</LINK>; <LINK REF="REF-Herderschee-2011" TYPE="REFERENCE">Herderschee 2011</LINK>), and there is a protocol (ongoing review) that will investigate electrostimulation (<LINK REF="REF-Gameiro-2012" TYPE="REFERENCE">Gameiro 2012</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-06-18 13:04:24 +0100" MODIFIED_BY="[Empty name]">
<P>The objective of this review is to determine the effectiveness of vaginal cones in the management of female urinary stress incontinence (SUI).</P>
<P>We wished to test the following comparisons in the management of stress incontinence:<BR/>1. vaginal cones versus no treatment;<BR/>2. vaginal cones versus other conservative therapies, such as PFMT and electrostimulation;<BR/>3. combining vaginal cones and another conservative therapy versus another conservative therapy alone or cones alone;<BR/>4. vaginal cones versus non-conservative methods, for example surgery or injectables.</P>
<P>Secondary issues which were considered included whether:<BR/>1. it takes less time to teach women to use cones than it does to teach the pelvic floor exercise;<BR/>2. self-taught use is effective;<BR/>3. the change in weight of the heaviest cone that can be retained is related to the level of improvement;<BR/>4. subgroups of women for whom cone use may be particularly effective can be identified.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-06-18 13:13:11 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-06-18 13:04:25 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-06-18 13:04:25 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Women whose predominant complaint is stress urinary incontinence (SUI), diagnosed either by symptom classification or urodynamics.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-05-07 04:49:29 +0100" MODIFIED_BY="[Empty name]">
<P>One arm of the study must have included the use of weighted vaginal cones following a standardised (within trial) protocol.</P>
<P>Comparators could include other conservative treatments such as pelvic floor muscle training (PFMT) or electrostimulation, or surgery, injectables etc. </P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-05-07 04:49:31 +0100" MODIFIED_BY="[Empty name]">
<P>1. Patient symptoms - perception of cure and improvement of urinary incontinence; number of incontinent episodes in 24 hours.<BR/>2. Quality of life measures - general health status (e.g. SF36), severity of incontinence, psychosocial measures, impact of incontinence.<BR/>3. Physical measures - change in weight of cone retained, perineometry or other measures of pelvic floor muscle strength, pad tests with measured leakage, ultrasound or radiographic measures of bladder neck descent and mobility.<BR/>4. Health economics - cost of interventions, resource implications of differences in outcome, formal economic analysis (e.g. cost effectiveness, cost utility), teaching time.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-06-18 13:11:30 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-06-18 13:11:30 +0100" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy developed for the Cochrane Incontinence Review Group. Relevant trials were identified from the Group's Specialised Register of controlled trials, which is described under the Incontinence Group's <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">module</A> in <I>The Cochrane Library</I>. The register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, CINAHL, and handsearching of journals and conference proceedings. Date of the most recent search of the Specialised Register for this review: 19 September 2012.</P>
<P>The trials in the Incontinence Group Specialised Register are also contained in CENTRAL. The terms used to search the Incontinence Group Specialised Register are given below:</P>
<P>({DESIGN.CCT*} OR {DESIGN.RCT*}) AND {INTVENT.PHYS.CONES}</P>
<P>(All searches were of the keyword field of Reference Manager 12, Thomson Reuters).</P>
<P>For this review additional searches were performed by one of the review authors. These are detailed below.</P>
<P>The following search terms were used in both MEDLINE (January 1966 to March 2013) and EMBASE (January 1988 to March 2013): vaginal and (cones or weights or balls), in both titles and abstracts.</P>
<P>A search for trial authors was also performed in both MEDLINE (January 1966 to Present) and EMBASE (January 1988 to Present) to locate extra reports for included trials. We last performed these searches in February 2013. Extra reports were found for both the Pieber and Cammu trials (<LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>; <LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-11-03 09:48:35 +0000" MODIFIED_BY="[Empty name]">
<P>The reference lists of relevant articles were searched for other possible relevant trials.</P>
<P>We did not impose any language or other restrictions on the articles that were found.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-06-18 13:13:11 +0100" MODIFIED_BY="G Peter Herbison">
<P> Any differences of opinion related to study inclusion, methodological quality or data extraction were resolved by discussion with a third party. </P>
<STUDY_SELECTION MODIFIED="2013-06-18 13:12:07 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed titles and abstracts of trials identified by the search. We recovered full-text versions for those considered potentially eligible, and at least two review authors checked eligibility. We excluded trials that were not randomised or quasi-randomised trials for incontinent patients. Excluded trials are listed, with reasons for their exclusion, in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-06-18 13:12:19 +0100" MODIFIED_BY="[Empty name]">
<P>Data were abstracted by the lead author and cross-checked by the co-author(s). In instances where data might have been collected but not reported, further clarification was sought from the authors of the trials. Included trial data were processed as described in the Cochrane Collaboration Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The pad tests used in the different studies varied dramatically from a 30-second stress test to a 24-hour test. In order that these could be combined, the different tests were dichotomised into improvement/no improvement, sometimes requiring the help of authors.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-06-18 13:12:36 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors independently assessed reports of trials under consideration for inclusion in the review for their methodological quality and appropriateness, without prior consideration of their results. The review authors made an independent assessment of methodological quality using the Cochrane Collaboration 'Risk of bias' tool, which includes quality of random allocation and concealment, description of dropouts and withdrawals, analysis by intention-to-treat, and 'blinding' during treatment and at outcome assessment.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-06-18 13:12:43 +0100" MODIFIED_BY="[Empty name]">
<P>Rate ratios (RR) were used for dichotomous data and mean differences (MD) for continuous data. 'Leakage episodes' is a count data outcome with a low mean, thus the data are likely to be positively skewed, but, despite this, means and standard deviations were used where possible.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-06-18 13:12:49 +0100" MODIFIED_BY="[Empty name]">
<P>No unit of analysis issues were found. Cross-over trials are unlikely to be conducted, but cluster randomised trials might be possible, for example in aged care.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-06-18 13:12:56 +0100" MODIFIED_BY="[Empty name]">
<P>We contacted trial authors requesting data when data, such as standard deviations, were missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-05-08 00:22:44 +0100" MODIFIED_BY="[Empty name]">
<P>Heterogeneity was assessed by means of visual inspection of the forest plot, the test for heterogeneity and the I<SUP>2</SUP> statistic.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-06-18 13:13:00 +0100" MODIFIED_BY="[Empty name]">
<P>There were too few studies to make funnel plots clearly interpretable, or to place any reliance on small sample bias statistics.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-06-18 13:13:04 +0100" MODIFIED_BY="[Empty name]">
<P>Data were combined when possible, using rate ratios (RR) for dichotomous data and mean differences (MD) for continuous data. A fixed-effect analysis was used to calculate the pooled estimates and their 95% confidence intervals (CI).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-06-18 13:13:11 +0100" MODIFIED_BY="[Empty name]">
<P>Trial data were sub-grouped by type of incontinence - either genuine stress incontinence based on a urodynamic diagnosis, or stress incontinence based upon a symptom classification. Other subgroup analyses, e.g. for type of electrostimulation, were not possible due to the small number of trials in each comparison.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-05-08 00:24:06 +0100" MODIFIED_BY="[Empty name]">
<P>It was not possible to conduct potential sensitivity analyses for methodological quality due to the small number of trials in each comparison.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-06-18 13:16:46 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-06-18 13:13:44 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-06-18 13:13:19 +0100" MODIFIED_BY="[Empty name]">
<P>This update, performed in 2013, found six extra trials to add to this review (<LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Gameiro-2010" TYPE="STUDY">Gameiro 2010</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>), in addition to the one added in 2007 (<LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>), and one ongoing trial (<LINK REF="STD-Driusso-2010" TYPE="STUDY">Driusso 2010</LINK>). This means that we identified a total of 23 trials that compared the use of vaginal cones with a comparison group. A further five studies were excluded (see below). The literature assessment process is documented with a PRISMA flow chart (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-06-18 13:13:37 +0100" MODIFIED_BY="[Empty name]">
<P>In total, twenty-three trials were included in this review. Seven of these were reported only as abstracts from conferences (<LINK REF="STD-Bourcier-1994" TYPE="STUDY">Bourcier 1994</LINK>; <LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>; <LINK REF="STD-Haken-1991" TYPE="STUDY">Haken 1991</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>), so reported limited results and details of the methods. One of the trials was still in progress when the abstract was written, so did not report complete results, and no further report has been identified (<LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>). Extra, unpublished information was provided by the authors for five trials (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Details of cone protocols</HEADING>
<P>Most of the cones groups in the trials used the same protocol, which was, after the initial training, to hold the cone in place for two sessions of 15 minutes per day. All but one of the trials that did not use this particular protocol used very similar ones:</P>
<OL>
<LI>
<LINK REF="STD-Laycock-1993" TYPE="STUDY">Laycock 1993</LINK> used two times per day for 10 minutes each;</LI>
<LI>
<LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK> used one time per day for 10 minutes;</LI>
<LI>
<LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK> used one time per day for 15 minutes;</LI>
<LI>
<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK> and <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK> asked women to exercise while holding the weighted balls two times a day and to carry the weight for one session of 15 minutes.</LI>
</OL>
<P>One trial was quite different (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>): it used a different type of cone, varied the weight by asking that the degree of reclining was varied, and instructed women to contract the pelvic floor muscles around the cone. So, with the exception of the Seo trial, the cones treatments were relatively homogeneous.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of cones</HEADING>
<P>The cone treatments used differed in the number of different weights available and the shape of the cones. Some of the trials used sets of cones with different numbers of weights:</P>
<OL>
<LI>seven used nine weights (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Laycock-1993" TYPE="STUDY">Laycock 1993</LINK>; <LINK REF="STD-Olah-1990" TYPE="STUDY">Olah 1990</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>);</LI>
<LI>seven used five weights (<LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>; <LINK REF="STD-Delneri-2000" TYPE="STUDY">Delneri 2000</LINK>; <LINK REF="STD-Haken-1991" TYPE="STUDY">Haken 1991</LINK>; <LINK REF="STD-Gameiro-2010" TYPE="STUDY">Gameiro 2010</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>);</LI>
<LI>one had three weights (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>);</LI>
<LI>and one trial used only one weight (<LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>).</LI>
</OL>
<P>One trial added a variable amount of weights to the cone (<LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>).</P>
<P>Two other trials used balls instead of cones (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>), with two weights used at a time, one when static and one when moving around: weights were increased halfway through treatment. Three trials used cones with an unknown number of weights (<LINK REF="STD-Bourcier-1994" TYPE="STUDY">Bourcier 1994</LINK>; <LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>). One trial used a single weight of cone, but in a sitting position, with the angle to which the back was reclined directly related to the weakness of the pelvic floor (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>). Most cones were conical at one end, but two trials used cylinders with rounded ends (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>), one used a cone with a waist that was gripped by the pelvic floor (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>), and two others used weighted balls (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Comparator interventions</HEADING>
<P>The comparison groups used a wide range of treatments. These have been grouped for the purposes of this review, so that all PFMT treatments were treated alike, as were the electrostimulation treatments. Electrostimulation is electrical stimulation of the pelvic floor, which is carried out in a wide variety of ways and is the subject of another Cochrane review that is in preparation (<LINK REF="REF-Gameiro-2012" TYPE="REFERENCE">Gameiro 2012</LINK>).</P>
<P>The authors of another Cochrane systematic review on pelvic floor muscle training found that low intensity training was not as effective as higher intensity training, but there were few other differences, including no evidence of extra benefit from biofeedback (feedback of biological information while undergoing treatment) (<LINK REF="REF-Hay_x002d_Smith-2006" TYPE="REFERENCE">Hay-Smith 2006</LINK>). In all the trials included in this review, the PFMT regimes would be considered as being of higher intensity. Other reviews may show whether combining different electrostimulation treatments is appropriate or not.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<P>The outcome measures that were used varied between trials. Many of the prespecified outcomes were reported by only one trial. Sometimes continuous outcomes were reported as differences from baseline, and sometimes the final values were presented. Standard deviations were often missing.</P>
<P>Subjective outcomes were worded and grouped differently, and urinary diaries were collected for different lengths of time with different measures reported. There were many different types of pad test. Two trials used both a short pad test and a 24-hour pad test (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>). Only the results from the short pad test were used in the formal comparisons, as this was more similar to the other pad tests used.</P>
<P>While perineometry (measurement of the strength of voluntary muscle contractions in the perineum) was usually measured in cm of water, the devices used were different and of unknown comparability. One trial used mm of mercury (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>).</P>
<P>The time at which the outcome was measured relative to the start and end of treatment was another characteristic that varied widely between trials. This is important because it is likely that some decrease in effectiveness will occur after the end of treatment.</P>
<P>One trial presented means as pad test results with no indication of the variation present (<LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>). As this was not comparable with the results of other trials these data have been omitted from the formal comparisons. This trial compared cones with electrostimulation plus PFMT, which is one of the less useful comparisons for practitioners, as electrostimulation and PFMT are seldom combined as they were in this trial.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of participants and types of incontinence</HEADING>
<P>One trial recruited pre-menopausal women (<LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>), and one post-menopausal women (<LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>), while another recruited women at three months postpartum (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</P>
<P>Most trials recruited women with urodynamically-proven genuine stress incontinence with few other inclusion or exclusion criteria. In seven trials, symptoms of stress incontinence were sufficient for women to be included (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>; <LINK REF="STD-Gameiro-2010" TYPE="STUDY">Gameiro 2010</LINK>; <LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>; <LINK REF="STD-Olah-1990" TYPE="STUDY">Olah 1990</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>), but in one study it was unclear what inclusion criteria had been used (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-06-18 13:13:44 +0100" MODIFIED_BY="[Empty name]">
<P>Eight trials were excluded from the review for a variety of reasons. Two of them examined the use of cones for primary prevention, and had recruited women who were not incontinent and thus did not meet the inclusion criteria for this review (<LINK REF="STD-Jonasson-1989" TYPE="STUDY">Jonasson 1989</LINK>; <LINK REF="STD-Norton-1990" TYPE="STUDY">Norton 1990</LINK>). One, when translated, was deemed not to be a randomised trial (<LINK REF="STD-Salinas-Casado-1999" TYPE="STUDY">Salinas Casado 1999</LINK>); another randomised women with urgency rather than stress incontinence (<LINK REF="STD-Lentz-1994" TYPE="STUDY">Lentz 1994</LINK>); one did not randomise women to cone therapy (<LINK REF="STD-Williams-2005" TYPE="STUDY">Williams 2005</LINK>); and one assigned women to groups on the basis of geographic proximity to a hospital, so was not a randomised trial (<LINK REF="STD-Parkkinen-2004" TYPE="STUDY">Parkkinen 2004</LINK>). In this update two trials were added to those excluded, one was a systematic review (<LINK REF="STD-Ferreira-2011" TYPE="STUDY">Ferreira 2011</LINK>), and one a trial of a resistance device to train the pelvic muscles (<LINK REF="STD-Delgado-2010" TYPE="STUDY">Delgado 2010</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-06-18 13:14:01 +0100" MODIFIED_BY="G Peter Herbison">
<P>The risk of bias of the included trials is presented in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<P>Due to the brevity of the reporting it was particularly difficult to assess the quality of the seven trials that were published in abstract form only (<LINK REF="STD-Bourcier-1994" TYPE="STUDY">Bourcier 1994</LINK>; <LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>; <LINK REF="STD-Haken-1991" TYPE="STUDY">Haken 1991</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>).</P>
<ALLOCATION MODIFIED="2013-06-18 13:13:55 +0100" MODIFIED_BY="[Empty name]">
<P>Only five of the 23 included trials reported blinded group allocation (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>); the other eighteen did not give enough information to allow this to be assessed, and one appeared to be a quasi-randomised trial that used alternation (<LINK REF="STD-Gameiro-2010" TYPE="STUDY">Gameiro 2010</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-06-18 13:13:56 +0100" MODIFIED_BY="[Empty name]">
<P>With physical therapies such as cones it is impossible to blind the participants to the treatment they are getting.</P>
<P>Much of the assessment was done by means of questionnaires completed by participants. Only two trials reported that blinded assessors were used for other measures (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-04-27 15:23:10 +0100" MODIFIED_BY="[Empty name]">
<P>All trials analysed women in the group to which they had been assigned. However, some trials had a high proportion of withdrawals, for many of whom there were no outcome data. Two trials reported treatment-related dropout (<LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>), with the Cammu trial having many more dropouts in the cones group than the comparison group, while Wilson had a high proportion of dropouts in all three treatment groups, and a moderately high proportion of dropouts in the control group.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-06-18 13:13:59 +0100" MODIFIED_BY="[Empty name]">
<P>While there is the usual incomplete reporting of, especially, continuous outcomes, there is no evidence that there were outcomes that were measured but remained unreported. Many of the studies made no mention of having recorded urinary (or bladder) diaries, which is the usual way of measuring the number of urine leakages, so would be considered an important outcome for women included in these trials.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-06-18 13:14:01 +0100" MODIFIED_BY="[Empty name]">
<P>The trials were small, so were more susceptible to outliers, and publication bias. Only two trials randomised more than 60 women to treatment with cones (n = 74, 36 cones alone and 38 PFMT plus cones, <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>; and n = 80, <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>). The other cones groups ranged in size from 10 to 60.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-06-18 13:16:46 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. Cones versus controls</HEADING>
<P>Five trials compared cones with control treatment, which was defined as no active management aimed at exercising the pelvic floor (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>). In none of these trials was the control arm a no treatment arm.</P>
<OL>
<LI>In one, the women in the control group were offered the use of a vaginal device, the Continence Guard (Coloplast AG), and about half of them used this (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>).</LI>
<LI>In another, the controls were asked to continue with their "normal" postnatal PFMT regime (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</LI>
<LI>In three trials the controls received a leaflet explaining the pelvic floor and describing pelvic floor muscle exercises (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>)</LI>
<LI>In two there was extra contact with a nurse (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>).</LI>
</OL>
<P>The populations of women recruited into these trials were different:</P>
<OL>
<LI>Bø, Castro and Williams recruited women with urodynamically-proven stress incontinence (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>);</LI>
<LI>while Pereira and Wilson recruited women with symptoms of incontinence three months postpartum (<LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</LI>
</OL>
<P>There was little overlap in the outcome measures collected.</P>
<P>Treatments with cones were better than control treatments in the subjective reporting of cure or improvement (risk ratio of failure to cure or improve (RR) 0.72, 95% confidence interval (CI) 0.52 to 0.99) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), and lack of cure (RR 0.84, 95% CI 0.76 to 0.94) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). For one of the included trials (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>), the numbers with "mild or no problem" were used to imply "cure or improvement". There was a small improvement in leakage episodes (mean difference 0.69, 95% CI 0.38 to 1.01) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>), but there were no statistically significant differences for pad test, or pelvic floor muscle strength, and the confidence intervals were generally wide.</P>
<P>In addition to the prespecified outcomes, Bø reported that cones were better than control for the leakage index (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>). There were no statistically significant differences on the 24-hour pad test, the social activity index, whether participants wanted further treatment, or whether the incontinence was problematic. Pereira reported that cones were better on two domains of the Kings Health Questionnaire (<LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>), and Castro reported improved quality of life using the Urinary Incontinence Quality of Life scale (I-QoL) (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Cones versus PFMT</HEADING>
<P>Thirteen trials compared cones with PFMT (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>; <LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Gameiro-2010" TYPE="STUDY">Gameiro 2010</LINK>; <LINK REF="STD-Haken-1991" TYPE="STUDY">Haken 1991</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>). There was limited overlap with the outcome measures, and all the regimens of PFMT were different.</P>
<P>There were no statistically significant differences in subjective improvement or cure (reported in six trials) (RR 0.97, 95% CI 0.75 to 1.24) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>); subjective cure (reported in five trials) (RR 1.01, 95% CI 0.91 to 1.13) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>); leakage episodes per day (reported in four trials) (MD 0.00, 95% CI -0.20 to 0.20) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>); no improvement in pad test (reported in six trials) (RR 1.00, 95% CI 0.76 to 1.31) (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>); or in pelvic floor muscle strength (reported in five trials) (mean difference (MD) -0.61, 95% CI -2.49 to 1.27) (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
<P>In addition to the prespecified outcomes:</P>
<OL>
<LI>Arvonen reported a difference in median grams of leakage in favour of vaginal balls, and no statistically significant difference in pelvic floor muscle strength (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>);</LI>
<LI>Bø reported that cones were worse than PFMT for the leakage index, and more of the cones group wanted further treatment, but there were no statistically significant differences on the other extra outcomes (24-hour pad test, social activity index, and whether the incontinence was problematic) (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>);</LI>
<LI>Cammu found no statistically significant differences between cones and PFMT for pads per week, visual analogue scales (VAS) for incontinence and distress, or whether patients requested surgery after the treatment period (<LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>);</LI>
<LI>Laycock found no statistically significant differences in quality of life assessed using the King's Health Questionnaire, pad usage, wet episodes or muscle contractibility, but standard deviations were not reported, so these data could not be added to the formal comparisons (<LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>);</LI>
<LI>Peattie found no statistically significant difference in the proportion referred to surgery at the end of treatment (<LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>);</LI>
<LI>Castro reported no difference in I-QoL scores (P value 0.65, <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>);</LI>
<LI>Harvey reported no statistically significant difference in either the Urinary Distress Inventory (UDI-6) or I-QoL (<LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>);</LI>
<LI>Pereira reported no statistically significant differences in three domains of the Kings Health Questionnaire.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Cones versus electrostimulation</HEADING>
<P>Six trials compared cones with electrostimulation (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Delneri-2000" TYPE="STUDY">Delneri 2000</LINK>; <LINK REF="STD-Olah-1990" TYPE="STUDY">Olah 1990</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). The electrostimulation regimens were quite different from each other. Olah taught women in both arms of the trial to contract their pelvic floor muscles and encouraged them to do this regularly (<LINK REF="STD-Olah-1990" TYPE="STUDY">Olah 1990</LINK>).</P>
<P>No statistically significant differences emerged between cones and electrostimulation in respect of the prespecified outcome measures, improvement (RR 1.26, 95% CI 0.85 to 1.87) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>); subjective cure (measured in three trials) (RR 1.24, 95% CI 0.98 to 1.59) (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>); improvement in pad test (RR 1.21, 95% CI 0.90 to 1.63) (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>); leakage of urine, or pelvic floor muscle strength. Again, confidence intervals were generally wide, so the results were consistent both with cones being better than electrostimulation and with cones being worse than electrostimulation.</P>
<P>In addition, Bø found no statistically significant differences between electrostimulation and cones on all the extra outcomes used: the social activity index, the 24-hour pad test, the leakage index, the proportion of participants wanting further treatment, and those rating their incontinence as unproblematic (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>). Delneri found no statistically significant difference in a VAS recording overall discomfort (<LINK REF="STD-Delneri-2000" TYPE="STUDY">Delneri 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Cones plus PFMT versus PFMT</HEADING>
<P>Cones plus PFMT were compared to PFMT alone in two trials (<LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>). None of the outcomes used in these two trials overlapped. No statistically significant differences were detected in outcome measures in either trial, and confidence intervals were all wide. In addition to the prespecified outcomes, Pieber found no statistically significant differences in urodynamic parameters (<LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5. Cones plus PFMT versus electrostimulation</HEADING>
<P>Three trials compared cones plus PFMT with electrostimulation (<LINK REF="STD-Laycock-1993" TYPE="STUDY">Laycock 1993</LINK>; <LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). Improvement on the pad test was the only common outcome (used in two trials). There was no statistically significant difference in this respect (RR 0.77, 95% CI 0.46 to 1.30) (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>), nor in any other outcome.</P>
<P>Seo found no statistically significant differences between groups for pad tests, maximal vaginal pressure, maximal urethral close pressure, duration of pelvic floor muscle contractions, daytime frequency, amount of urine leakage, difficulty in doing exercises due to incontinence, sexual life, daily life, avoiding places, difficulty in personal relationships, or quality of life (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">6. Cones versus cones plus PFMT</HEADING>
<P>Cones alone were compared with cones plus PFMT in two trials (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). Neither of these trials identified any statistically significant differences between the groups, but all confidence intervals were wide. The only outcome the two trials had in common was improvement on pad testing (RR 0.95, 95% CI 0.54 to 1.68) (<LINK REF="CMP-006.02" TYPE="ANALYSIS">Analysis 6.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">7. Cones versus PFMT plus electrostimulation</HEADING>
<P>In a comparison of cones versus PFMT plus electrostimulation, Terry reported no statistically significant difference in pad tests at six weeks or six months, and no statistically significant differences in the proportions willing to continue treatment (<LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">8. Cones versus non-conservative treatments</HEADING>
<P>There were no trials that addressed this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">9. Different methods of using cones</HEADING>
<P>One trial compared active versus passive use of cones (<LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>). For passive use, the cones were simply held in the vagina, but for active use the women carried out a standard series of activities while holding the cones. There were no statistically significant benefits of the active treatment. The only outcome reported that could be used was no leakage after coughing with active compared to passive treatment, a RR of 0.72 (95% CI 0.36 to 1.42) (21/30 (70%) versus 18/31 (58%)).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">10. Other considerations</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">i. Other comparisons</HEADING>
<P>One trial compared PFMT plus cones with electrostimulation plus PFMT with biofeedback (<LINK REF="STD-Bourcier-1994" TYPE="STUDY">Bourcier 1994</LINK>). It was difficult to classify this trial into any of the above comparisons. There were no statistically significant differences reported between the two treatments.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ii. Quality of life</HEADING>
<P>Seven trials reported on quality of life (<LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>; <LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>; <LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>), and, even though the same questionnaire was used in three trials (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>), no standard deviations for the scores were reported, so they could not be combined. Four trials in this 2013 update reported similar improvements in the quality of life scores in all of the treatment groups (cones, electrostimulation, pelvic floor muscle training) when compared to the controls (<LINK REF="STD-Castro-2008" TYPE="STUDY">Castro 2008</LINK>; <LINK REF="STD-Harvey-2006" TYPE="STUDY">Harvey 2006</LINK>; <LINK REF="STD-Pereira-2012" TYPE="STUDY">Pereira 2012</LINK>; <LINK REF="STD-Santos-2009" TYPE="STUDY">Santos 2009</LINK>). There were no reported differences between these differing interventions and the quality of life improvements. For the other trials, Seo used a five-point Likert scale (<LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>), and Bø reported a social activity index which may be related to quality of life (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>). Bø and Burton both reported a leakage index (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>). Wilson also reported measures of sexual satisfaction, which did not differ significantly between treatment groups (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">iii. Economic measures</HEADING>
<P>No trial reported economic measures. One trial reported teaching time and found no statistically significant difference between teaching the use of cones and the teaching of PFMT (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>). Peattie assigned shorter teaching times to the cones group and found no statistically significant difference between it and the PFMT group (<LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>), while Wise simply gave verbal instruction in the use of cones (<LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">iv. Method of instruction</HEADING>
<P>Most trials taught the use of the cones and how to do a pelvic floor muscle contraction but Wise gave only verbal instruction (<LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). The results in this trial did not differ from those in which the women received more comprehensive instruction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">v. Sensitivity analysis</HEADING>
<P>It was decided that no sensitivity analyses were possible to explore the effects of methodological quality due to the uniformity of the quality and the lack of similar, combinable, outcomes in most of the trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">vi. Acceptability of treatment/dropouts</HEADING>
<P>One-hundred and fifty-nine of the 717 women (22%, range 0 to 72%) treated with cones withdrew or dropped out during treatment. For treatment with cones only, the number of dropouts was 94 out of 482 women (20%, range 0 to 47% with one study 72%). Treatment with cones plus PFMT resulted in 65 out of 175 women dropping out of treatment (37%, range 24% to 63%). In the comparison treatments the numbers of dropouts were 34 out of 209 (16%) for the control treatments, 82 out of 383 (21%) for the PFMT only treatments and 20 out of 135 (15%) for those receiving electrostimulation. In addition, <LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK> had 19 out of 30 (63%) of women drop out of treatment with PFMT and electrostimulation. Few trials examined the reasons for women dropping out of treatment, but those that did gave reasons that included motivation problems, unpleasantness, aesthetic dislike, discomfort, bleeding, and vaginal prolapse. None of these seemed to be predominant.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-06-18 13:16:59 +0100" MODIFIED_BY="G Peter Herbison">
<SUMMARY_OF_RESULTS MODIFIED="2013-06-18 13:16:51 +0100" MODIFIED_BY="[Empty name]">
<P>The limited evidence available suggests that cones benefit women with stress urinary incontinence compared to no active treatment. Cones appear to be similar to both PFMT and electrostimulation in its various forms. Using cones in conjunction with PFMT appeared to produce no extra benefit, and the results were statistically compatible with both better, and worse, performance.</P>
<P>As a result of few trials addressing each comparison, combined with the small size of the trials, there are wide confidence intervals around many of the results. To put this another way, for most of the comparisons the data are compatible both with cones being clearly worse or clearly better than the comparison treatment, so the place of cones in the treatment of SUI cannot be determined accurately with the data currently available to us.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-04-27 15:52:41 +0100" MODIFIED_BY="[Empty name]">
<P>The protocols for treatment with cones were relatively standard, but the number of different weights of cones used, as well as the differences between two successive cone weights, varied among the trials. Most trials used five or more cones with weight differences of 12.5 g or less. One trial used three cones with weight differences of 20 g and 30 g (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>). Some of the cones were of a different shape to the others (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>; <LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>; <LINK REF="STD-Terry-1996" TYPE="STUDY">Terry 1996</LINK>), and three trials used a shorter duration of treatment (<LINK REF="STD-Laycock-1993" TYPE="STUDY">Laycock 1993</LINK>; <LINK REF="STD-Laycock-2001" TYPE="STUDY">Laycock 2001</LINK>; <LINK REF="STD-Pieber-1995" TYPE="STUDY">Pieber 1995</LINK>). Arvonen used weighted balls, with the same two weights for all women, but used different weights for different exercises (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-Arvonen-2002" TYPE="STUDY">Arvonen 2002</LINK>). The weights were increased halfway through the treatment. While these differences could theoretically affect the treatment, there were no trials comparing treatment with different types of cone so no direct comparisons could be made. A comparison across trials did not show any obvious differences.</P>
<P>The treatments within the comparison groups varied widely, to the extent that there is some doubt about the validity of combining them. The PFMT regimes required different numbers of daily contractions; some women were instructed to do fast and slow contractions while some were not; there were different training times; and different amounts of contact with a therapist. Some trials provided limited details of the regimens. There is some experimental evidence that certain PFMT regimens are better than others (<LINK REF="REF-Hay_x002d_Smith-2006" TYPE="REFERENCE">Hay-Smith 2006</LINK>). The intensity of PFMT may have been greater in some trials, such as <LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>. This may have affected the relative performance of the interventions, but the data were too few to test for interaction between treatment effect and subgroups of trials. Electrostimulation also varied, with differences in location of stimulation (internal or external), the electrical frequencies used, and the length of each treatment. Internal stimulation was carried out daily at home (<LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>), or in the clinic (<LINK REF="STD-Delneri-2000" TYPE="STUDY">Delneri 2000</LINK>), whereas external stimulation was delivered at the clinic several times a week (<LINK REF="STD-Laycock-1993" TYPE="STUDY">Laycock 1993</LINK>; <LINK REF="STD-Olah-1990" TYPE="STUDY">Olah 1990</LINK>; <LINK REF="STD-Seo-2004" TYPE="STUDY">Seo 2004</LINK>). Again, these differences could alter the effectiveness of electrostimulation, but it was not possible to address this issue in this review.</P>
<P>There was no direct comparison of different ways of teaching the use of the cones. It might be possible to use cones successfully without much in the way of teaching. Wise gave only verbal instruction, similar to those written on the instructions that come with the cones, and achieved results that did not differ from those in trials with more teaching time (<LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). There was also no significant effect from teaching active versus passive use of the cones (<LINK REF="STD-Burton-1993" TYPE="STUDY">Burton 1993</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-06-18 13:16:59 +0100" MODIFIED_BY="[Empty name]">
<P>All trials were small with the largest randomising only 80 women to the use of cones (<LINK REF="STD-Williams-2006" TYPE="STUDY">Williams 2006</LINK>).</P>
<P>Many of the trials had considerable numbers of withdrawals, in spite of efforts to include all participants in the analysis. Some of the trials commented on the drop-out rate of women from the groups using cones. Some mentioned that few women wanted to continue with them after the treatment period, although others did wish to do so. The drop-out rate was roughly similar in most of the groups within each trial, with only one trial having a markedly higher rate in the cones group compared to the comparison group (<LINK REF="STD-Cammu-1998" TYPE="STUDY">Cammu 1998</LINK>). In some cases, for physical reasons, treatment with cones may be difficult, and some women appear to find them unpleasant to use.</P>
<P>The interpretation is hindered by problems with the trials. Usually the reporting was poor, with much crucial information missing. Seven of the 23 included trials were reported as abstracts only, and one of these reported only preliminary results. Unpublished information was available for just four of the trials (<LINK REF="STD-Arvonen-2001" TYPE="STUDY">Arvonen 2001</LINK>; <LINK REF="STD-B_x00f8_-1999" TYPE="STUDY">Bø 1999</LINK>; <LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>).</P>
<P>Many different outcome measures were reported, which made it difficult to combine results. Often the trials - especially those reported only as abstracts - did not present results for all the outcomes measured. Particular difficulty was encountered with the results of pad testing. Just about every pad test was different, ranging from very short, at 30 seconds, to 24 hours, with variation in conditions such as the fullness of the bladder at the start of the test. Variation in pad testing is a common problem in incontinence research and hinders comparison of treatments (<LINK REF="REF-Soroka-2002" TYPE="REFERENCE">Soroka 2002</LINK>). The results were also presented differently, with some trials using grams of leakage, some presenting difference pre to post treatment, and some just presenting improvement. The results in grams of leakage were highly skewed, which caused the mean to be a poor measure to use. Pad testing itself is also a fairly unreliable outcome measure, as it has low repeatability. As a result of these problems it was decided to use simple improvement on the pad test as the common outcome, where this was possible. This is not very satisfactory as it does not use much of the information available. Pad testing is discussed further elsewhere (<LINK REF="REF-Ryhammer-1999" TYPE="REFERENCE">Ryhammer 1999</LINK>).</P>
<P>The use of pelvic floor muscle strength as an outcome measure is also subject to difficulties, as it is a surrogate outcome of questionable reliability, and its correlation with continence or change in continence is unknown. Different techniques of measuring may give different results. This outcome is included in this review because, if weighted cones do improve continence it is likely to be because they train and strengthen the pelvic floor. Data were sufficiently alike in the two trials that reported this outcome to allow the results to be combined to provide a weighted mean difference. However, there were no significant differences between any of the comparisons which provided these data.</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-06-18 13:17:07 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-06-18 13:17:02 +0100" MODIFIED_BY="[Empty name]">
<P>There was some evidence that vaginal cones may be better than no active treatment in women with stress incontinence, with limited evidence that they are similar to other conservative treatments. The 23 trials included in this review reported that between 0% and 72% (average 22%) of women stopped using cones early. These drop-out rates were similar to those for electrostimulation or pelvic floor muscle training. Cones remain an option that may appeal to some: if conservative therapy is contemplated, then cones could be offered as one option for training the pelvic floor muscles, in the hope that one type of training is acceptable.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-06-18 13:17:07 +0100" MODIFIED_BY="G Peter Herbison">
<P>The place of cones in the physical treatment of stress incontinence is yet to be decided. This review has not been able to rule out that there may be clinically significant differences between different conservative methods of treating stress incontinence. Larger, well conducted trials need to be carried out. These should have a standard, minimum set of outcomes that are easy to report and combine with other trials. These outcomes should include: a subjective report of cure or improvement measured on a five-point scale; a standardised pad test, reported as improvement on the test or improvement by more than a given amount as well as grams of leakage; quality of life measures; economic outcomes; and possibly a test of pelvic floor muscle strength. These should be measured after a suitable duration of treatment (at least long enough to be able to affect muscle that has been damaged in some way) and some time after that to see if any changes persist. The purpose of treatment is to provide long-term continence, so outcomes should be measured at least at six months, and preferably one year, after treatment. Prior to randomisation, it may be worthwhile having a run-in period of treatment with cones for both the cones and comparison group(s) to establish which methods are acceptable.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-07-08 11:15:56 +0100" MODIFIED_BY="[Empty name]">
<P>The authors would like to thank Stan Plevnik for his co-authorship of the first two versions of this review, and Jill Mantle for her co-authorship on the first three versions of the review.</P>
<P>Thanks to Jean Hay-Smith for useful discussions on the form of the review and comments on the draft review. We would like to thank Tiina Arvonen, Kari Bø and Alison Peattie for the provision of unpublished data.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-06-18 13:17:12 +0100" MODIFIED_BY="[Empty name]">
<P>Peter Herbison was the co-author of one of the included trials (<LINK REF="STD-Wilson-1998" TYPE="STUDY">Wilson 1998</LINK>), and a previous author of this review, Stan Plevnik was a co-author of two of the trials included (<LINK REF="STD-Peattie-1988a" TYPE="STUDY">Peattie 1988a</LINK>; <LINK REF="STD-Wise-1993" TYPE="STUDY">Wise 1993</LINK>). Stan Plevnik was the originator of the idea of weighted vaginal cones.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-03-30 00:33:20 +0000" MODIFIED_BY="G Peter Herbison">
<P>Peter Herbison assessed the studies, extracted the data and wrote the review. Nicola Dean checked the new data and commented on the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-07-08 11:18:18 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-07-08 11:18:18 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-07-08 11:17:53 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Arvonen-2001" NAME="Arvonen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arvonen T, Fianu-Jonasson A, Tyni-Lenné R</AU>
<TI>Effectiveness of two conservative modes of physical therapy in women with urinary stress incontinence</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>591-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arvonen-2002" MODIFIED="2013-06-18 14:58:05 +0100" MODIFIED_BY="G Peter Herbison" NAME="Arvonen 2002" YEAR="2002">
<REFERENCE MODIFIED="2013-06-18 14:58:05 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arvonen T, Jonasson AF, Tyni-Lenné R</AU>
<TI>A clinical trial comparing conventional pelvic floor training and training with vaginal balls in women with stress urinary incontinence &#8212; a pilot study</TI>
<SO>Nordisk Fysioterapi</SO>
<YR>2002</YR>
<VL>6</VL>
<NO>1</NO>
<PG>41&#8211;6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bourcier-1994" MODIFIED="2013-06-18 14:58:29 +0100" MODIFIED_BY="[Empty name]" NAME="Bourcier 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-06-18 14:58:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bourcier A, Juras J</AU>
<TI>Randomised study comparing physiotherapy and pelvic floor rehabilitation</TI>
<SO>Proceedings of the 24th Annual Meeting of the International Continence Society; 1994 Aug 30-Sept 3; Prague</SO>
<YR>1994</YR>
<PG>146</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burton-1993" MODIFIED="2013-06-18 14:58:15 +0100" MODIFIED_BY="[Empty name]" NAME="Burton 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-06-18 14:58:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Burton G</AU>
<TI>Active vaginal cone therapy: a new form of treatment for genuine stress incontinence (abstract)</TI>
<SO>Proceedings of the 23rd Annual Meeting of the International Continence Society (Conference proceedings: Read by title)</SO>
<YR>1993</YR>
<PG>A134</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-B_x00f8_-1999" MODIFIED="2013-06-18 14:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Bø 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bø K, Talseth T, Holme I</AU>
<TI>Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>318</VL>
<PG>487-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-18 14:58:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bø K, Talseth T</AU>
<TI>Single blind randomised controlled trial on the effect of pelvic floor muscle strength training, electrical stimulation, cones or control on severe genuine stress incontinence. Abstract 87</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>4</NO>
<PG>421-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cammu-1998" MODIFIED="2013-06-18 14:20:27 +0100" MODIFIED_BY="[Empty name]" NAME="Cammu 1998" YEAR="1998">
<REFERENCE MODIFIED="2013-06-18 14:20:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Cammu H, Van Nylen M</AU>
<TI>Pelvic floor exercises (PFE) versus vaginal cones (VC) in the treatment of genuine stress incontinence (Abstract number 225)</TI>
<SO>Proceedings of the 26th Annual Conference of the International Continence Society; 1996 Aug 27-30; Athens, Greece</SO>
<YR>1996</YR>
<PG>223</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cammu H, Van Nylen M</AU>
<TI>Pelvic floor exercises versus vaginal weight cones in genuine stress incontinence</TI>
<SO>European Journal of Obstetrics Gynecology and Reproductive Biology</SO>
<YR>1998</YR>
<VL>77</VL>
<PG>89-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Castro-2008" MODIFIED="2013-04-22 22:04:24 +0100" MODIFIED_BY="[Empty name]" NAME="Castro 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-04-22 22:04:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Castro RA, Arruda RM, Zanetti MRD, Santos PD, Sartori MGF, Girao MJBC</AU>
<TI>Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence</TI>
<SO>Clinics</SO>
<YR>2008</YR>
<VL>64</VL>
<PG>465-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delneri-2000" NAME="Delneri 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delneri C, di Benedetto P</AU>
<TI>Pelvic floor rehabilitation. A comparison of two methods of treatment: vaginal cones versus functional electrical stimulation</TI>
<SO>Europa Medicophysica</SO>
<YR>2000</YR>
<VL>36</VL>
<PG>45-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gameiro-2010" MODIFIED="2013-07-08 11:17:53 +0100" MODIFIED_BY="[Empty name]" NAME="Gameiro 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-03-13 20:57:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gameiro MO, Moreira EH, Gameiro FO, Moreno JC, Padovani CR, Amaro JL</AU>
<TI>Vaginal weight cone versus assisted pelvic floor muscle training in the treatment of female urinary incontinence. A prospective, single-blind, randomized trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>4</NO>
<PG>395-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-08 11:17:53 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreira E, Orsi Gameiro M, Fugita OEH, Kawano PR, Yamamoto HA, Amaro JL</AU>
<TI>Vaginal weight cone versus assisted pelvic floor muscle training in the treatment of female urinary incontinence. A prospective, single-blind, randomized trial (Abstract 1703)</TI>
<SO>The Journal of Urology</SO>
<YR>2009</YR>
<VL>181</VL>
<NO>4, Supplement</NO>
<PG>614</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haken-1991" NAME="Haken 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haken J, Benness C, Cardozo L, Cutner A</AU>
<TI>A randomised trial of vaginal cones and pelvic floor exercises in the management of genuine stress incontinence. Abstract 76</TI>
<SO>Neurourology &amp; Urodynamics</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>4</NO>
<PG>393-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harvey-2006" MODIFIED="2011-03-02 22:55:41 +0000" MODIFIED_BY="G Peter Herbison" NAME="Harvey 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-03-02 22:55:41 +0000" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harvey M-A, Johnston SL</AU>
<TI>A randomized, single-blind, prospective trial comparing pelvic floor physiotherapy with biofeedback versus weighted vaginal cones in the treatment of female genuine stress urinary incontinence: a pilot study (Abstract 318)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S235-S236</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laycock-1993" NAME="Laycock 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laycock J, Jerwood D</AU>
<TI>Does pre-modulated interferential therapy cure genuine stress incontinence?</TI>
<SO>Physiotherapy</SO>
<YR>1993</YR>
<VL>79</VL>
<NO>8</NO>
<PG>553-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laycock-2001" MODIFIED="2013-06-18 14:58:53 +0100" MODIFIED_BY="[Empty name]" NAME="Laycock 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-06-18 14:58:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laycock J, Brown J, Cusack C, Green S, Jerwood D, Mann K et al</AU>
<TI>A multi-centre, prospective, randomised, controlled, group comparative study of the efficacy of vaginal cones and PFX. Abstract 47</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>4</NO>
<PG>301-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laycock J, Brown J, Cusack C, Green S, Jerwood D, Mann K et al</AU>
<TI>A multicentre, prospective, randomised, controlled, group comparative study of the efficacy of vaginal cones and PFX (Abstract)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>1999</YR>
<VL>10</VL>
<NO>Suppl 1</NO>
<PG>S49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Laycock J, Brown J, Cusack C, Green S, Jerwood D, Mann K et al</AU>
<TI>Pelvic floor reeducation for stress incontinence: comparing three methods</TI>
<SO>British Journal of Community Nursing</SO>
<YR>2001</YR>
<VL>6</VL>
<NO>5</NO>
<PG>230-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olah-1990" MODIFIED="2013-06-18 14:59:11 +0100" MODIFIED_BY="[Empty name]" NAME="Olah 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-06-18 14:59:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bridges N, Denning J, Olah KS, Farrar DJ</AU>
<TI>A prospective trial comparing interferential therapy and treatment using cones in patients with symptoms of stress incontinence. Abstract 73</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>3</NO>
<PG>267-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-18 14:59:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Olah KS, Bridges N, Denning J, Farrar DJ</AU>
<TI>The conservative management of patients with symptoms of stress incontinence: a randomized prospective study comparing weighted vaginal cones and interferential therapy</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<PG>87-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Peattie-1988a" MODIFIED="2013-06-18 14:59:19 +0100" MODIFIED_BY="G Peter Herbison" NAME="Peattie 1988a" YEAR="1988">
<REFERENCE MODIFIED="2013-06-18 14:59:19 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Peattie A, Plevnik S</AU>
<TI>Cones versus physiotherapy as conservative management of genuine stress incontinence. Abstract 72</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>3</NO>
<PG>265-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 22:34:25 +0000" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Peattie AB, Taylor B, Plevnik S, Stanton SL</AU>
<TI>Cones versus physiotherapy for conservative treatment of genuine stress incontinence (Abstract number 169)</TI>
<SO>Proceedings of the Silver Jubilee British Congress of Obstetrics and Gynaecology</SO>
<YR>1989 Jul 4-7</YR>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pereira-2012" MODIFIED="2013-03-12 04:02:25 +0000" MODIFIED_BY="G Peter Herbison" NAME="Pereira 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-03-12 04:00:49 +0000" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pereira VS, de Melo MV, Correia GN, Driusso P</AU>
<TI>Long-term effects of pelvic floor muscle training with vaginal cone in post-menopausal women with urinary incontinence: a randomized controlled trial</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2013</YR>
<VL>32</VL>
<PG>48&#8211;52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-03-12 04:02:25 +0000" MODIFIED_BY="G Peter Herbison" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pereira VS, de Melo MV, Correia GN, Driusso P</AU>
<TI>Vaginal cone for postmenopausal women with stress urinary incontinence: randomized, controlled trial</TI>
<SO>Climacteric</SO>
<YR>2012</YR>
<VL>15</VL>
<PG>45&#8211;51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pieber-1995" MODIFIED="2013-06-18 14:59:30 +0100" MODIFIED_BY="[Empty name]" NAME="Pieber 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pieber D, Zivkovic F, Tamussino K, Ralph G, Lippitt G, Fauland B</AU>
<TI>Pelvic floor exercise alone or with vaginal cones for the treatment of mild to moderate stress urinary incontinence in premenopausal women</TI>
<SO>International Urogynecology Journal</SO>
<YR>1995</YR>
<VL>6</VL>
<PG>14-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-18 14:32:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Pieber D, Zivkovic F, Tamussino K, Ralph G</AU>
<TI>Pelvic floor exercise alone or with vaginal cones for the treatment of mild and moderate stress incontinence in premenopausal women: a randomised trial (Abstract)</TI>
<SO>Proceedings of the 24th Annual Meeting of the International Continence Society; 1994 Aug 27-Sept 2; Prague (Czech Republic) (Conference proceedings: Read by title)</SO>
<YR>1994</YR>
<PG>162</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-18 14:59:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pieber D, Zivkovic F, Tamussino K</AU>
<TI>Pelvic floor exercises alone or with vaginal cones in premenopausal women with mild to moderate stress incontinence</TI>
<TO>Beckenbodengymnastik allien oder mit vaginalkonin bei prämenopausalen frauen mit milder und mässiger stressharninkontinenz</TO>
<SO>Gynäkologisch-Geburtshilfliche Rundschau</SO>
<YR>1994</YR>
<VL>34</VL>
<PG>32-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santos-2009" MODIFIED="2013-06-18 14:59:43 +0100" MODIFIED_BY="G Peter Herbison" NAME="Santos 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-18 14:59:43 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santos PFD, Oliveira E, Zanetti MRD, Arruda RM, Sartori MGF, Girão MJBC et al</AU>
<TI>Electrical stimulation of the pelvic floor versus vaginal cone therapy for the treatment of stress urinary incontinence</TI>
<TO>Eletroestimulação funcional do assoalho pélvico versus terapia com os cones vaginais para o tratamento de incontinência urinária de esforço (Portuguese)</TO>
<SO>Revista Brasileira de Ginecologia e Obstetríca</SO>
<YR>2009</YR>
<VL>31</VL>
<NO>9</NO>
<PG>447-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seo-2004" NAME="Seo 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seo JT, Yoon H, Kim YH</AU>
<TI>A randomized prospective study comparing new vaginal cone and FES-Biofeedback</TI>
<SO>Yonsei Medical Journal</SO>
<YR>2004</YR>
<VL>45</VL>
<NO>5</NO>
<PG>879-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Terry-1996" MODIFIED="2013-06-18 14:59:58 +0100" MODIFIED_BY="[Empty name]" NAME="Terry 1996" YEAR="1996">
<REFERENCE MODIFIED="2013-06-18 14:59:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Terry PB, White SM</AU>
<TI>Randomised trial comparing Enhance with physiotherapy for the treatment of GSI</TI>
<SO>Proceedings of the 26th Annual Meeting of the International Continence Society; 1996 Aug 27-30; Athens (Greece)</SO>
<YR>1996</YR>
<PG>248-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Williams-2006" MODIFIED="2013-06-18 15:00:11 +0100" MODIFIED_BY="G Peter Herbison" NAME="Williams 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-06-18 15:00:11 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams K, Coleby D, Abrams K, Shaw C, Assassa P, McGrouther C</AU>
<TI>Randomised controlled trial of the clinical effectiveness of services for urinary symptoms: six year follow-up (Abstract number 45)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>660-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-02 22:38:48 +0000" MODIFIED_BY="G Peter Herbison" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Williams KS, Assassa RP, Gillies CL, Abrams KR, Turner DA, Shaw C et al and the Leicestershire MRC Incontinence Study Team</AU>
<TI>A randomized controlled trial of the effectiveness of pelvic floor therapies for urodynamic stress and mixed incontinence</TI>
<SO>BJU International</SO>
<YR>2006</YR>
<VL>98</VL>
<PG>1043-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wilson-1998" NAME="Wilson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson PD, Herbison GP</AU>
<TI>A randomized controlled trial of pelvic floor muscle exercises to treat postnatal urinary incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>1998</YR>
<VL>9</VL>
<PG>257-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wise-1993" MODIFIED="2013-06-18 15:00:21 +0100" MODIFIED_BY="[Empty name]" NAME="Wise 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-06-18 15:00:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wise BG, Haken J, Cardozo LD, Plevnik S</AU>
<TI>A comparative study of vaginal cone therapy, cones + Kegel exercises, and maximal electrical stimulation in the treatment of female genuine stress incontinence. Abstract 76</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1993</YR>
<VL>12</VL>
<NO>4</NO>
<PG>436-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-06-18 15:01:05 +0100" MODIFIED_BY="G Peter Herbison">
<STUDY DATA_SOURCE="PUB" ID="STD-Delgado-2010" MODIFIED="2013-06-18 14:44:40 +0100" MODIFIED_BY="G Peter Herbison" NAME="Delgado 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-18 14:44:40 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delgado D, Drake M</AU>
<TI>A randomised controlled trial of the Pelvic Toner Device in female stress urinary incontinence</TI>
<SO>British Journal of Urology International</SO>
<YR>21 September 2010</YR>
<VL>www2.bjui.org/ContentFullitem.aspx?id=427&amp;SectionType=4</VL>
<PG>1&#8211;7 (last accessed 18 June 2013)</PG>
<IDENTIFIERS MODIFIED="2013-03-26 03:12:31 +0000" MODIFIED_BY="G Peter Herbison">
<IDENTIFIER MODIFIED="2013-03-26 03:12:31 +0000" MODIFIED_BY="G Peter Herbison" TYPE="OTHER" VALUE="Web only publication"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ferreira-2011" MODIFIED="2013-06-18 15:00:34 +0100" MODIFIED_BY="G Peter Herbison" NAME="Ferreira 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-06-18 15:00:34 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferreira M, Santos P</AU>
<TI>Pelvic floor muscle training programmes: a systematic review</TI>
<TO>Nos programas de treino dos músculos do pavimento pélvico [Portuguese]</TO>
<SO>Acta Médica Portuguesa</SO>
<YR>2011</YR>
<VL>24</VL>
<PG>309&#8211;18</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jonasson-1989" NAME="Jonasson 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jonasson A, Larsson B, Pschera H</AU>
<TI>Testing and training of the pelvic floor muscles after childbirth</TI>
<SO>Acta Obstetricia Gynecologica Scandinavica</SO>
<YR>1989</YR>
<VL>68</VL>
<PG>301-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lentz-1994" MODIFIED="2013-06-18 14:57:10 +0100" MODIFIED_BY="[Empty name]" NAME="Lentz 1994" YEAR="1994">
<REFERENCE MODIFIED="2013-06-18 14:57:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lentz G, Plevnik S, Stanton SL</AU>
<TI>Vaginal cones versus bladder drill for sensory urgency treatment (Abstract)</TI>
<SO>Proceedings of the 24th Annual Meeting of the International Continence Society (Conference proceedings: Read by title)</SO>
<YR>1994</YR>
<PG>35-6</PG>
<CY>Prague</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norton-1990" MODIFIED="2013-06-18 15:00:51 +0100" MODIFIED_BY="[Empty name]" NAME="Norton 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-06-18 15:00:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Norton P, Baker J</AU>
<TI>Randomized prospective trial of vaginal cones vs. Kegel exercises in postpartum primiparous women. Abstract 85</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1990</YR>
<VL>9</VL>
<NO>4</NO>
<PG>434-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parkkinen-2004" NAME="Parkkinen 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parkkinen A, Karjalainen E, Vartiainen M, Penttinen J</AU>
<TI>Physiotherapy for female stress urinary incontinence: individual therapy at the outpatient clinic versus home-based pelvic floor training: A five-year follow-up study</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<PG>643-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salinas-Casado-1999" NAME="Salinas Casado 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salinas Casado J, Virseda Charmorro M, Esteban Fuertes M</AU>
<TI>The therapeutic efficacy of vaginal cones in rehabilitating the perineal musculature. The RECOVA Group</TI>
<TO>Eficacia terapéutica de los conos vaginales en la rehabilitación de la musculatura perineal</TO>
<SO>Archivos Espanoles de Urologia</SO>
<YR>1999</YR>
<VL>52</VL>
<NO>1</NO>
<PG>53-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2005" MODIFIED="2013-06-18 15:01:05 +0100" MODIFIED_BY="[Empty name]" NAME="Williams 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-18 15:01:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams KS, Assassa RP, Cooper NJ, Turner DA, Shaw C, Abrams KR, et al and the Leicester MRC Incontinence Study Team</AU>
<TI>Clinical and cost-effectiveness of a new nurse-led continence service: a randomised controlled trial</TI>
<SO>British Journal of General Practice</SO>
<YR>2005</YR>
<VL>55</VL>
<PG>696-703</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES MODIFIED="2013-07-08 11:18:18 +0100" MODIFIED_BY="G Peter Herbison">
<STUDY DATA_SOURCE="PUB" ID="STD-Driusso-2010" MODIFIED="2013-07-08 11:18:18 +0100" MODIFIED_BY="G Peter Herbison" NAME="Driusso 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-07-08 11:18:18 +0100" MODIFIED_BY="G Peter Herbison" PRIMARY="NO" TYPE="OTHER">
<AU>Driusso P, Correia GN, Pereira VS, Aveiro MC, de Melo MV, Tahara N</AU>
<TI>Physiotherapy for women with stress urinary incontinence: effects of kinesiotherapy, vaginal cones and electrical stimulation</TI>
<SO>Australian New Zealand Clinical Trials Registry</SO>
<YR>25 March 2010</YR>
<VL>ACTRN12610000254099</VL>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-06-18 15:02:41 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-06-18 15:02:41 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abrams-1989" NAME="Abrams 1989" TYPE="JOURNAL_ARTICLE">
<AU>Abrams P, Blaivas J, Stanton S, Anderson J</AU>
<TI>The standardisation of terminology of lower urinary tract function</TI>
<SO>World Journal of Urology</SO>
<YR>1989</YR>
<VL>6</VL>
<PG>233-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bump-1991" MODIFIED="2013-06-18 15:01:17 +0100" MODIFIED_BY="G Peter Herbison" NAME="Bump 1991" TYPE="JOURNAL_ARTICLE">
<AU>Bump RC, Hurt WG, Fantl A, Wyman JF</AU>
<TI>Assessment of Kegel pelvic muscle exercise performance after brief verbal instruction</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>165</VL>
<PG>322-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bump-1992a" MODIFIED="2013-06-18 15:01:26 +0100" MODIFIED_BY="[Empty name]" NAME="Bump 1992a" TYPE="JOURNAL_ARTICLE">
<AU>Bump R, Sugerman H, Fantl J</AU>
<TI>Obesity and lower urinary tract function in women: effect of surgically induced weight loss</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<PG>392-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bump-1992b" MODIFIED="2013-06-18 15:01:41 +0100" MODIFIED_BY="[Empty name]" NAME="Bump 1992b" TYPE="JOURNAL_ARTICLE">
<AU>Bump R, McClish D</AU>
<TI>Cigarette smoking and urinary incontinence in women</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<PG>1213-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-B_x00f8_-1995" NAME="Bø 1995" TYPE="JOURNAL_ARTICLE">
<AU>Bø K</AU>
<TI>Vaginal weight cones. Theoretical framework, effect on pelvic floor muscle strength and female stress urinary incontinence</TI>
<SO>Acta Obstetricia Gynecologica Scandinavica</SO>
<YR>1995</YR>
<VL>74</VL>
<PG>87-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deindl-1995" NAME="Deindl 1995" TYPE="JOURNAL_ARTICLE">
<AU>Deindl FM, Schussler B, Vodusek DB, Hesse U</AU>
<TI>Neurophysiological effect of vaginal cone application in continent and urinary stress incontinent women</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>1995</YR>
<VL>6</VL>
<PG>204-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dumoulin-2010" MODIFIED="2013-05-17 05:06:23 +0100" MODIFIED_BY="[Empty name]" NAME="Dumoulin 2010" TYPE="COCHRANE_REVIEW">
<AU>Dumoulin C, Hay-Smith J</AU>
<TI>Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2013-05-17 05:01:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD005654.pub2"/>
<IDENTIFIER TYPE="OTHER" VALUE="CD005654"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gameiro-2012" MODIFIED="2013-03-26 03:44:40 +0000" MODIFIED_BY="G Peter Herbison" NAME="Gameiro 2012" TYPE="COCHRANE_PROTOCOL">
<AU>Gameiro LFO, El Dib RP, Gameiro MO, Amaro JL</AU>
<TI>Electrical stimulation with non-implanted electrodes for overactive bladder in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2013-03-26 03:44:40 +0000" MODIFIED_BY="G Peter Herbison">
<IDENTIFIER MODIFIED="2013-03-26 03:44:31 +0000" MODIFIED_BY="G Peter Herbison" TYPE="DOI" VALUE="10.1002/14651858.CD010098"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hahn-1996" MODIFIED="2013-06-18 15:01:55 +0100" MODIFIED_BY="[Empty name]" NAME="Hahn 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hahn I, Milsom I, Ohlsson BL, Ekelund P, Uhlemann C, Fall M</AU>
<TI>Comparative assessment of pelvic floor function using vaginal cones, vaginal digital palpatation and vaginal pressure measurements</TI>
<SO>Gynecology and Obstetric Investigation</SO>
<YR>1996</YR>
<VL>41</VL>
<PG>269-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hanzal-1993" NAME="Hanzal 1993" TYPE="JOURNAL_ARTICLE">
<AU>Hanzal E, Berger E, Koelbl H</AU>
<TI>Levator ani muscle morphology and recurrent genuine stress incontinence</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1993</YR>
<VL>81</VL>
<PG>426-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-2006" MODIFIED="2013-04-22 22:06:19 +0100" MODIFIED_BY="G Peter Herbison" NAME="Hay-Smith 2006" TYPE="COCHRANE_REVIEW">
<AU>Hay-Smith EJC, Dumoulin C</AU>
<TI>Pelvic floor muscle training versus no treatment or inactive control treatments, for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2013-04-22 22:06:19 +0100" MODIFIED_BY="G Peter Herbison">
<IDENTIFIER MODIFIED="2013-04-22 22:06:19 +0100" MODIFIED_BY="G Peter Herbison" TYPE="DOI" VALUE="10.1002/14651858.CD005654"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-2011" MODIFIED="2013-05-17 05:06:52 +0100" MODIFIED_BY="[Empty name]" NAME="Hay-Smith 2011" TYPE="COCHRANE_REVIEW">
<AU>Hay-Smith EJC, Herderschee R, Dumoulin C, Herbison GP</AU>
<TI>Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>12</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2013-05-17 05:01:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD009508"/>
<IDENTIFIER TYPE="OTHER" VALUE="CD009508"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herderschee-2011" MODIFIED="2013-05-17 05:05:39 +0100" MODIFIED_BY="[Empty name]" NAME="Herderschee 2011" TYPE="COCHRANE_REVIEW">
<AU>Herderschee R, Hay-Smith E. Jean C., Herbison GP, Roovers JP, Heineman MJ</AU>
<TI>Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2013-05-17 05:01:31 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD009252"/>
<IDENTIFIER TYPE="OTHER" VALUE="CD009252"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-05-16 12:33:32 +0100" MODIFIED_BY="G Peter Herbison" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hu-1990" NAME="Hu 1990" TYPE="JOURNAL_ARTICLE">
<AU>Hu T</AU>
<TI>Impact of urinary incontinence on health-care costs</TI>
<SO>Journal of American Geriatric Society</SO>
<YR>1990</YR>
<VL>38</VL>
<PG>292-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jolleys-1988" NAME="Jolleys 1988" TYPE="JOURNAL_ARTICLE">
<AU>Jolleys JV</AU>
<TI>Reported prevalence of urinary incontinence in women in a general practice</TI>
<SO>BMJ</SO>
<YR>1988</YR>
<VL>296</VL>
<PG>1300-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kegel-1951" NAME="Kegel 1951" TYPE="JOURNAL_ARTICLE">
<AU>Kegel AH</AU>
<TI>Physiologic therapy for urinary stress incontinence</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1951</YR>
<VL>146</VL>
<PG>915-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lagro_x002d_Janssen-1994" NAME="Lagro-Janssen 1994" TYPE="JOURNAL_ARTICLE">
<AU>Lagro-Janssen AL, Smits AJ, van Weel C</AU>
<TI>Beneficial effect of exercise therapy in urinary incontinence in family practice depends largely on therapy compliance and motivation</TI>
<SO>Nederlandse Tijdschrift Geneeskunde</SO>
<YR>1994</YR>
<VL>138</VL>
<PG>1273-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miller-1996" MODIFIED="2013-06-18 15:02:06 +0100" MODIFIED_BY="[Empty name]" NAME="Miller 1996" TYPE="JOURNAL_ARTICLE">
<AU>Miller J, Ashton-Miller JA, DeLancy OL</AU>
<TI>The knack: use of precisely-timed pelvic muscle contraction can reduce leakage in SUI</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>1996</YR>
<VL>15</VL>
<PG>392-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morley-1995" NAME="Morley 1995" TYPE="JOURNAL_ARTICLE">
<AU>Morley R, Cumming J, Weller R</AU>
<TI>Morphology and neuropathology of the pelvic floor in patients with stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>1995</YR>
<VL>7</VL>
<PG>3-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peattie-1988b" MODIFIED="2013-06-18 15:02:14 +0100" MODIFIED_BY="[Empty name]" NAME="Peattie 1988b" TYPE="JOURNAL_ARTICLE">
<AU>Peattie AB, Plevnik S, Stanton SL</AU>
<TI>Vaginal cones: a conservative method of treating genuine stress incontinence</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1988</YR>
<VL>95</VL>
<PG>1049-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Plevnik-1985" NAME="Plevnik 1985" TYPE="CONFERENCE_PROC">
<AU>Plevnik S</AU>
<TI>New method for testing and strengthening of pelvic floor muscles</TI>
<SO>Proceedings of the 15th Annual Meeting of the International Continence Society</SO>
<YR>1985</YR>
<PG>267-8</PG>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryhammer-1999" NAME="Ryhammer 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ryhammer AM, Djurhuus JC, Laurberg S</AU>
<TI>Pad testing in incontinent women: a review</TI>
<SO>International Urogynecology Journal</SO>
<YR>1999</YR>
<VL>10</VL>
<PG>111-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1989a" MODIFIED="2013-06-18 15:02:23 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 1989a" TYPE="JOURNAL_ARTICLE">
<AU>Smith ARB, Hosker GL, Warrell DW</AU>
<TI>The role of partial denervation of the pelvic floor in the aetiology of genitourinary prolapse and stress incontinence of urine. A neurophysiological study</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1989</YR>
<VL>96</VL>
<PG>24-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1989b" MODIFIED="2013-06-18 15:02:31 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 1989b" TYPE="JOURNAL_ARTICLE">
<AU>Smith ARB, Hosker GL, Warrell DW</AU>
<TI>The role of pudendal nerve damage in the aetiology of genuine stress incontinence in women</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1989</YR>
<VL>96</VL>
<PG>29-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Snooks-1984" NAME="Snooks 1984" TYPE="JOURNAL_ARTICLE">
<AU>Snooks SJ, Swash M, Setchell M, Henry MM</AU>
<TI>Injury to innervation of pelvic floor sphincter musculature in childbirth</TI>
<SO>Lancet</SO>
<YR>1984</YR>
<VL>2</VL>
<PG>546-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Soroka-2002" NAME="Soroka 2002" TYPE="JOURNAL_ARTICLE">
<AU>Soroka D, Drutz HP, Glazener CMA, Hay-Smith EJC, Ross SJ</AU>
<TI>Perineal pad test in evaluating outcome of treatments for female incontinence: a systematic review</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2002</YR>
<VL>13</VL>
<NO>3</NO>
<PG>165-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walters-1992" NAME="Walters 1992" TYPE="JOURNAL_ARTICLE">
<AU>Walters MD, Realini JP, Dougherty M</AU>
<TI>Nonsurgical treatment of urinary incontinence</TI>
<SO>Current Opinion in Obstetrics &amp; Gynecology</SO>
<YR>1992</YR>
<VL>4</VL>
<PG>554-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilson-1996" MODIFIED="2013-06-18 15:02:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wilson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wilson PD, Herbison RM, Herbison GP</AU>
<TI>Obstetric practice and the prevalence of urinary incontinence three months after delivery</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<PG>154-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wyman-1990" NAME="Wyman 1990" TYPE="JOURNAL_ARTICLE">
<AU>Wyman JF, Harkins SW, Fantl JA</AU>
<TI>Psychosocial impact of urinary incontinence in the community-dwelling population</TI>
<SO>Journal of American Geriatric Society</SO>
<YR>1990</YR>
<VL>38</VL>
<PG>282-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-07-08 11:17:32 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-06-18 13:17:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arvonen-2001">
<CHAR_METHODS MODIFIED="2013-06-18 13:17:16 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed RCT. Method of group allocation: not stated. Whether assessor blinded to group allocation: not stated. Duration of treatment was 4 months, final results measured at the end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:17:16 +0100" MODIFIED_BY="[Empty name]">
<P>40 women with symptoms of stress incontinence, age &lt; 65 y, and an understanding of spoken Swedish. Median (range) age was 49 y (32-64 y) in the vaginal ball group, and 47 y (28-65 y) in the PFMT group. Parity, BMI, duration of symptoms and score on the Sense of Coherence scale were well matched at randomisation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:17:18 +0100" MODIFIED_BY="[Empty name]">
<P>1. Weighted vaginal balls (n = 20): starting with a ball weighing 65 g, PFMs were squeezed maximally for 20 s, then relaxed for 20 s, with this repeated 10 times. This was done twice daily. In addition, the 50 g ball was retained while moving for 15 min daily. After 2 months the balls were replaced by ones weighing 100 g and 80 g<BR/>2. PFMT (n = 20): 10 maximum PFM squeezes while sitting (5-s squeeze, then 5-s break) with a short break after 5 squeezes. Repeated while standing. Whole sequence repeated twice daily. In addition, a 3-s submaximal squeeze followed by a 3-s rest was repeated 15 times once a day</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:17:21 +0100" MODIFIED_BY="[Empty name]">
<P>Short provocation (60 seconds with standard exercises) pad test with a standard 300 ml in bladder<BR/>Vaginal strength measured by digital palpation. Subjective score on a 4-point scale (good/fully recovered, improved, no change, worse)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:17:27 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 2/20 in the vaginal balls group, and 1/20 in the PFMT group. Balls made by Vagitrim, Ipex Medical AB, Stockholm, Sweden</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:18:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arvonen-2002">
<CHAR_METHODS MODIFIED="2013-06-18 13:17:40 +0100" MODIFIED_BY="G Peter Herbison">
<P>2-armed parallel RCT. Method of group allocation: not clear. Treatment for 4 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:17:50 +0100" MODIFIED_BY="[Empty name]">
<P>24 female participants with stress incontinence. Inclusion criteria were leakage of 1-12 g, age 30-65 y and able to understand spoken Swedish. Exclusion criteria were pregnancy, cysto/rectocele, prolapse, ongoing vaginal infection and medication affecting urinary tract function. Women had a mean age of 42 y (range 30-57 y), a mean BMI of 24 (range 19&#8211;33), mean number of pregnancies was 2 (range 1&#8211;8) and mean duration of symptoms was 6 y (range 1&#8211;18 y).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:18:26 +0100" MODIFIED_BY="G Peter Herbison">
<P>The participants visited the clinics 3 times for assessments and twice for learning the training. All participants were instructed in pelvic floor anatomy and function, and their ability to contract their PFM properly was checked on the first visit. Both groups received verbal information and a written programme from a physiotherapist. The group training with vaginal balls also received a set of vaginal balls</P>
<P>1. PFMT (10 completed the study). 10 contractions 4 times a day performed in both sitting and standing positions. Each contraction supposed to last for 5 s followed by 5 s relaxation. In the second week 15 maximal dynamic contractions of 3-4 s followed by relaxation for 3&#8211;4 s and a maximal static contraction for 2 min were added. From the third week the following were also added (all in the supine position with legs bent): contraction-cough 3 times; contraction pelvic lifting 3 times; and contraction sit-up 3 times</P>
<P>2. Vaginal balls (7 completed the study). (Vagitrim, 2 with a diameter of 28 mm weighing 50 g and 65 g, and 2 with a diameter of 32 mm weighing 80 g and 100 g). During the first 2 months the two lighter balls were used for training, and in the following 2 months the heavier two were used. Pelvic floor contraction with the heaviest ball was performed standing, with a foot's-length distance between the feet. A maximal contraction for 20 s held the ball in, followed by 20 s of sitting. This was done 10 times, 4 times a day for a total of 40 contractions. In addition, the lightest ball was used once a day for 30 min while performing activities like walking, doing gymnastics, coughing and lifting</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:18:29 +0100" MODIFIED_BY="G Peter Herbison">
<P>Provocation pad test (standard bladder volume of 275 ml followed by standard exercises). Pelvic muscle strength measured by vaginal palpation. Patients subjective assessment on a 4-point ordinal scale, good, improved, no change, worse</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:18:31 +0100" MODIFIED_BY="G Peter Herbison">
<P>Pilot study. 2/12 in the PFMT group and 5/12 in the vaginal ball group did not complete the study. Data were reported and medians and range, so not usable apart from the ordinal subjective assessment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-08 11:11:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bourcier-1994">
<CHAR_METHODS MODIFIED="2013-06-18 13:18:44 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed RCT. Method of group allocation: not stated. Whether assessor blinded to treatment allocation: not stated. Duration of treatment was 3 months, outcomes were assessed at 6 months from start of treatment. Active period of treatment differed between the 2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:18:45 +0100" MODIFIED_BY="[Empty name]">
<P>102 women with urodynamically proven stress incontinence. Mean age was 38 y</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-08 11:11:41 +0100" MODIFIED_BY="[Empty name]">
<P>1. PFMT + cones (n = 50): 3 months of 20 maximal PF contractions 3 times daily, plus use of unspecified cones twice daily and different exercise with instructor for 30 min once a week. After 3 months encouraged to continue the home treatment<BR/>2. Electrical stimulation with biofeedback (n = 52): 6 weeks with 2 x 30-min sessions/week: 20 min short-term maximal functional electrical stimulation (parameters unspecified), and 10 min of Electromyography/pressure biofeedback. After 3 months attended clinic weekly</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:20:22 +0100" MODIFIED_BY="[Empty name]">
<P>Continence status<BR/>Unspecified pad test<BR/>Urodynamics<BR/>PFM strength and endurance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:20:26 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 12/50 in PFMT + cones group, and 6/52 in the electrical stimulation + biofeedback group<BR/>Only abstract published</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:21:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burton-1993">
<CHAR_METHODS MODIFIED="2013-06-18 13:20:58 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed RCT. Method of allocation: not stated. Whether assessors blinded: not stated. Duration of treatment not specified, nor the point at which the outcome was measured</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:20:59 +0100" MODIFIED_BY="[Empty name]">
<P>61 women with urodynamically proven GSI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:21:00 +0100" MODIFIED_BY="[Empty name]">
<P>1. Passive cones (n = 31): 15 min twice daily in a static position with unspecified cones<BR/>2. Active cones (n = 30): 15 min twice daily while doing standardised activities that previously caused incontinence. Unspecified cones</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:21:05 +0100" MODIFIED_BY="[Empty name]">
<P>Urodynamics<BR/>Cough till leak<BR/>40-min pad test<BR/>Visual analogue symptom score<BR/>Leakage activity index<BR/>Psychological adjustment to illness scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:21:07 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes reported for all participants<BR/>Only abstract published</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:21:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-B_x00f8_-1999">
<CHAR_METHODS MODIFIED="2013-06-18 13:21:39 +0100" MODIFIED_BY="[Empty name]">
<P>4-armed RCT. Group allocation was blinded. Assessor was blinded to treatment allocation. Assessment was at 6 months from start of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:21:40 +0100" MODIFIED_BY="[Empty name]">
<P>122 women with urodynamically proven GSI. The mean age was 49.5 y (range 24-70 y) and mean duration of symptoms was 10.8 y (range 1-45 y)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:21:43 +0100" MODIFIED_BY="[Empty name]">
<P>1. Control (n = 32): offered the use of the Continence Guard (Coloplast AS)<BR/>2. PFMT (n = 29): 8-12 maximum contractions 3 times daily plus 1 group session/week<BR/>3. Electrical stimulation (n = 32): maximum intermittent stimulation with MS106 Twin (Vitacon AS), 50 Hz, pulse width 0.2 ms, current 0-120 mA, 30 min every day<BR/>4. Cones (n = 29): 20 min daily. Mabella cones, 3 cylindrical weights: 20 g, 40 g, 70 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:21:48 +0100" MODIFIED_BY="[Empty name]">
<P>Stress pad test (30 s running on the spot then 30 s of jumping jacks)<BR/>24-hour pad test<BR/>3-day leakage episodes<BR/>Subjective ratings<BR/>Leakage index<BR/>Social activity index<BR/>Pelvic floor muscle strength</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:21:49 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 2/32 in controls, 4/29 in PFMT, 7/32 electrical stimulation, and 2/29 in the cones group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:22:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cammu-1998">
<CHAR_METHODS MODIFIED="2013-06-18 13:21:54 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel RCT. Method of group allocation: not stated. No attempt at blinding assessment. Duration of treatment: 12 weeks, outcome assessed at end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:21:55 +0100" MODIFIED_BY="[Empty name]">
<P>60 women with urodynamically proven GSI. PFMT group had a mean age of 55.9 y (SD 9.5), while the cones group had a mean age of 56.3 y (SD 11.4). Duration of symptoms: 6.7 y (SD 7.2) in PFMT group, and 5.3 y (SD 5.2) in cones group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:21:57 +0100" MODIFIED_BY="[Empty name]">
<P>1. PFMT (n = 30): initial training plus 1 30-min visit/week. 10 fast and 10 slow 10-s contractions for 2 periods of 15 min daily<BR/>2. Cones (n = 30): initial training, plus holding cones for 15 min twice daily. Femina cones, 5 conical weights, 20-70 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:21:59 +0100" MODIFIED_BY="[Empty name]">
<P>Urinary diaries (leakages/week)<BR/>Pad use<BR/>VAS of severity and psychological distress</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:22:00 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: after the first visit 14/30 women in the cones group withdrew, so did not receive the treatment. None of the electrostimulation group withdrew. All participants are in the analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:22:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Castro-2008">
<CHAR_METHODS MODIFIED="2013-06-18 13:22:06 +0100" MODIFIED_BY="[Empty name]">
<P>4-armed parallel RCT. Method of group allocation not stated. The sole outcome assessor was blinded for outcomes that could be blinded. Treatment was for 6 months with outcomes measured at the end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:22:13 +0100" MODIFIED_BY="[Empty name]">
<P>118 women with urodynamic stress urinary incontinence and no detrusor overactivity, a positive cough stress test, and &gt; 3 g leakage measured by a pad test with a standardised bladder volume (200 ml). At least 3 stress incontinence episodes/week. Exclusion of women with chronic degenerative diseases, advanced genital prolapse, pregnancy, active or recurrent urinary tract infections, vulvovaginitis, atrophic vaginitis, continence surgery within 1 year and patients with pacemakers. Also excluded were women with intrinsic sphincteric deficiencies defined by the Valsalva leak point pressure of &#8804; 60 cm water</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:22:35 +0100" MODIFIED_BY="[Empty name]">
<P>All participants were taught to contract the pelvic floor muscles correctly. All active treatments were at a urogynaecology unit 3 times/week under the supervision of a trained physical therapist</P>
<P>1. Pelvic floor muscle training (31 randomised, 26 at assessment). 10 repetitions of 5-s contractions with 5-s recovery, 20 repetitions of 2-s contractions with 2-s recovery, 20 repetitions of 1-s contractions with 1-s recovery, 5 repetitions of 10-s contractions with 10-s recovery followed by 5 repetitions of strong contractions together with a stimulated cough with 1 min interval between sets. General exercises before and after. Exercise in a 45-min group session</P>
<P>2. Electrical stimulation group (30 randomised, 27 at assessment). Cylindrical electrodes, 10 cm long and 3.5 cm wide with a double metal ring. Inserted into the middle third of the vagina. 50 Hz frequency, 5-s on and 10-s off cycle with a pulse width of 0.5 milliseconds. At maximum current intensity tolerated by patient. Each treatment was for 20 min</P>
<P>3. Vaginal cones group (27 randomised, 24 at assessment). 9 cones of equal shape and volume increasing in weight from 20-100 g. Used weight that just required tensing to the pelvic floor to retain, Instructed to leave the cone in for 45 min</P>
<P>4. No treatment group (30 randomised, 24 at assessment). Received a motivational phone call once a month</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:22:36 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome a negative pad test (&lt; 2 g) with a standardised bladder volume (200 ml). Secondary outcomes were QoL as measured by the I-QoL, number of leakages recorded in the voiding diary, urodynamic testing, and subjective cure (measured as satisfied/dissatisfied)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:22:38 +0100" MODIFIED_BY="[Empty name]">
<P>Only completers analysed. 17 (14%) withdrew, 5 from the PFMT group, 3 from the ES group, 3 from the cones group, and 6 from the no treatment group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:22:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delneri-2000">
<CHAR_METHODS MODIFIED="2013-06-18 13:22:51 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel RCT. Method of group allocation: not stated. Whether assessors blinded: not stated. Cones treatment lasted 4 weeks; electrical stimulation lasted 16 days. Outcomes assessed at the end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:22:51 +0100" MODIFIED_BY="[Empty name]">
<P>20 women with urodynamically proven stress incontinence. Cones group mean age 49.5 y, range 29-81 y (SD 14.5). Electrical stimulation group mean age 41.5 y, range 31-54 y (SD 7.4)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:22:54 +0100" MODIFIED_BY="[Empty name]">
<P>1. Cones (n = 10): held cones for 25-35 min daily for 4 weeks. Femcon cones, 5 conical weights, 20-70 g<BR/>2. Functional electrical stimulation (n = 10): 12 consecutive 30-min sessions (excluding Saturday and Sunday). 15 min at 20 Hz and 15 min at 50 Hz. Pulse duration 4 s with 8 s recovery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:22:56 +0100" MODIFIED_BY="[Empty name]">
<P>Perineal assessment<BR/>Unspecified pad test<BR/>Urodynamics<BR/>Visual analogue score of overall discomfort caused by incontinence</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:22:57 +0100" MODIFIED_BY="[Empty name]">
<P>2 women from the cones group refused follow-up urodynamics</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:24:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gameiro-2010">
<CHAR_METHODS MODIFIED="2013-06-18 13:24:08 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective single-blind randomised trial. VWC vs APFMT in treatment of urinary incontinence. Participants were systematically allocated into 2 groups, odd numbers into group 1 and even numbers into group 2. Outcomes assessed at 6 and 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:24:12 +0100" MODIFIED_BY="[Empty name]">
<P>103 women referred to the gynaecologist with the predominant symptom of stress urinary incontinence (50% also had urge incontinence). None of the participants had an urodynamic diagnosis of SUI, taken anticholingerics or been treated using pelvic floor exercises or bladder training. The average age in the VWC group was 49 y and 48 y in the APFMT group</P>
<P>Group 1 (n = 51) VWC</P>
<P>Group 2 (n = 52) APFMT</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:24:19 +0100" MODIFIED_BY="[Empty name]">
<P>The protocols consisted of 1 40-min session/week over a 12-week period. Patients treated with VWC were assisted by a single physiotherapist, cones varied from 20-70g, and needed to be held in the vagina while walking on the flat, coughing 3 times and then stepping up and down a 2-step stair 10 times. Patients treated with APFMT should perform 2 series of 10 exercises controlled by verbal commands of a single physiotherapist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:24:24 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes assessed at 0, 6 and 12 months</P>
<P>Clinical questionnaire, VAS for assessing the degree of bother in wetness and discomfort, 60-minute pad test, subjective evaluation of PFM using transvaginal digital palpation and objective assessment of PFM using a perineometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:24:25 +0100" MODIFIED_BY="[Empty name]">
<P>No dropouts</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:24:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haken-1991">
<CHAR_METHODS MODIFIED="2013-06-18 13:24:48 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel study. Method of group allocation: not stated. No attempt to blind assessment. All women were taught the appropriate anatomy and physiology. Women seen at 2, 6 and 10 weeks, with outcome assessments at 10 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:24:49 +0100" MODIFIED_BY="[Empty name]">
<P>64 women with urodynamically proven GSI, with a mean age of 48 y</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:24:50 +0100" MODIFIED_BY="[Empty name]">
<P>1. Cones (n = 31): held cone for 15 min twice daily. Femina cones, 5 conical weights, 20-70 g<BR/>2. PFMT (n = 33): 5 contractions 10 times daily</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:24:52 +0100" MODIFIED_BY="[Empty name]">
<P>ICS standard 40-min pad test<BR/>VAS (details not reported)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:24:54 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: all women were followed up but 3/33 in the PFMT group, and 8/31 in the cones group withdrew from treatment<BR/>Only abstract published</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-08 11:12:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harvey-2006">
<CHAR_METHODS MODIFIED="2013-06-18 13:25:06 +0100" MODIFIED_BY="[Empty name]">
<P>A single-blinded RCT. Randomised to biofeedback or cones group. Review by research team at 6 months to assess outcomes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:25:11 +0100" MODIFIED_BY="[Empty name]">
<P>Adult clinic patients with symptoms of mainly stress incontinence and confirmed USI on urodynamics. Excluded : &gt; 65 y old, detrusor overactivity, past treatment with cones or biofeedback or electrical stimulation or surgery, pelvic organ prolapse quantification stage &gt; 3</P>
<P>19 women randomised to biofeedback, 25 to cones group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-08 11:12:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Biofeedback - randomised to biofeedback for 10 weekly sessions with a trained nurse</P>
<P>2. Cones - cones used for 15-20 min daily. If the cone is successfully held for this period for 5 consecutive days then the weight of the cone is increased. </P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes studied included the presence of USI at 6 months, questionnaires (UDI-6 and I-QoL) and a urine loss on 30-min pad test (with a fixed volume 300 ml)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:25:25 +0100" MODIFIED_BY="G Peter Herbison" STUDY_ID="STD-Laycock-1993">
<CHAR_METHODS MODIFIED="2013-06-18 13:25:19 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel trial. Method of group allocation: not stated. No attempt at blinding assessment. Women in the electrotherapy (interferential therapy) group agreed not to perform PFMT for the duration of the trial. Treatment for an average of 6 weeks, with assessment within 2 weeks of last treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:25:19 +0100" MODIFIED_BY="[Empty name]">
<P>46 women with urodynamically proven GSI, 23 in each arm. Aged from 28-59 y, with mean duration of symptoms of 7 y, with sterile urine</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:25:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Premodulated interferential (electro) therapy (n = 23): bipolar technique, used an Endomed 433. 1st treatment 15 min, subsequent ones 30 min. 3 different frequencies for 10 min each, 1 Hz, 10-40 Hz, and 40 Hz<BR/>2. Cones and PFMT (n = 23): 5 maximum contractions of individualised duration every hour of the day. Cones supplied 2nd visit, used cones for 10 min, 2 times/day. Femina cones, 9 conical weights, 20-100 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:25:23 +0100" MODIFIED_BY="G Peter Herbison">
<P>Stress pad test<BR/>Change in digital grading<BR/>Subjective assessment<BR/>Frequency/volume charts (urinary diaries)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:25:25 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: none in interferential therapy group, 6/23 in the cones + PFMT group<BR/>Many outcomes reported with not enough detail to be included</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:25:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laycock-2001">
<CHAR_METHODS MODIFIED="2013-06-18 13:25:31 +0100" MODIFIED_BY="[Empty name]">
<P>3-armed parallel RCT. Allocation concealment: not stated. Blinding of assessors: not stated. Duration of treatment 3 months, with outcomes assessed at the end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:25:33 +0100" MODIFIED_BY="[Empty name]">
<P>101 women, in 5 sites, with symptoms of SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:25:37 +0100" MODIFIED_BY="[Empty name]">
<P>1. Cones (n = 41): 10 min daily. Aquaflex cones with unstated number of different weights. 3 months of treatment. Treatment discontinued during menstruation<BR/>2. Biofeedback (n = 40): using the PFX (a modified Kegel Perineometer). Individually assessed number of fast and slow contractions, lying and standing for 10 min daily. Increased the number over the 3-month period. Treatment discontinued during menstruation<BR/>3. PFMT (n = 20): individually assessed number of fast and slow contractions lying, sitting, and standing for 10 min daily. Treatment continued during menstruation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:25:39 +0100" MODIFIED_BY="[Empty name]">
<P>Primary measures:<BR/>Reduction in the frequency of incontinence<BR/>VAS of severity<BR/>Secondary measures:<BR/>Use of pads<BR/>Increase in maximum muscle contraction<BR/>QoL measured by the King's Health Questionnaire</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:25:39 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 11/41 in the cones group, 18/40 in the PFX group and 4/20 in the PFMT group<BR/>Supported by the makers of the cones and the PFX device</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:25:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olah-1990">
<CHAR_METHODS MODIFIED="2013-06-18 13:25:45 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel design. Method of group allocation: not stated. No attempt at blinding assessment. Assessment was both immediately after treatment, and 6 months from the start of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:25:46 +0100" MODIFIED_BY="[Empty name]">
<P>69 women with symptoms of incontinence, who had not had treatment with PFMT in the last 6 months. Age of the interferential (electrotherapy) group was 47.9 y (SD 13.0), and 43.2 y (SD 8.9) in the cones group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:25:47 +0100" MODIFIED_BY="[Empty name]">
<P>1. Interferential therapy (n = 36): at a clinic 3 times/week for 4 weeks. Patient semi-recumbent position with 4 vacuum electrodes, 2 on the abdomen and 2 on the inside of the thighs. Frequency 0-100 Hz sweeps, maximum tolerable intensity and each treatment for 15 min. Encouraged to perform PFMT<BR/>2. Cones (n = 33): weekly clinic visit for 4 weeks. Held cones for 15 min twice daily. Femina cones, 9 conical weights, 20-100 g. Encouraged to perform PFMT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:25:50 +0100" MODIFIED_BY="[Empty name]">
<P>Subjective response<BR/>ICS 1-hour pad test<BR/>Weight of cone held<BR/>Grams of leakage/week assessed through urinary diaries</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:25:50 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 6/36 in electrostimulation group, 9/23 in cones + PFMT arm. All withdrawals included in analysis. All participants were taught pelvic floor exercises, with no further details about this</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:26:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peattie-1988a">
<CHAR_METHODS MODIFIED="2013-06-18 13:26:00 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel RCT. Method of group allocation: not stated. No attempt at blinding assessment. Duration of treatment was 4 weeks, with assessment at the end of treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:26:01 +0100" MODIFIED_BY="[Empty name]">
<P>44 premenopausal women with urodynamically proven GSI who were waiting for surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:26:04 +0100" MODIFIED_BY="[Empty name]">
<P>1. PFMT (n = 22): 1-hour initial session, 30-min session a week later, then 15-min 3 weeks later.<BR/>2. Cones (n = 22): held cone for 15 min twice daily. Weekly telephone call. Femina cones, 9 conical weights, 20-100 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:26:05 +0100" MODIFIED_BY="[Empty name]">
<P>Extended pad test<BR/>Subjective cure<BR/>Referral to surgery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:26:07 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 5/22 in the cones group, and 6/22 in the PFMT group<BR/>Abstract publication was of a continuing trial, with some participants awaiting assessment. More complete information was available from the authors</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-08 11:13:02 +0100" MODIFIED_BY="G Peter Herbison" STUDY_ID="STD-Pereira-2012">
<CHAR_METHODS MODIFIED="2013-06-18 13:26:17 +0100" MODIFIED_BY="G Peter Herbison">
<P>3-armed RCT. Method of group allocation: sealed envelopes. Blinding not possible. Outcome measures at end of treatment and 6 weeks post treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-08 11:13:02 +0100" MODIFIED_BY="G Peter Herbison">
<P>45 post-menopausal women (no vaginal bleeding for &gt; 12 months), with at least 1 episode of urine leakage during the previous month. Leakage had to be SUI as defined by a positive answer to the Kings Health Questionnaire question "Do you lose urine with physical activities such as coughing, sneezing, running?". Exclusion criteria: previous treatment/surgery for urinary incontinence or hormone therapy, ongoing urinary tract infections, cognitive or neurological disorders, uncontrolled hypertension, and inability to perform the proposed procedures</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:26:33 +0100" MODIFIED_BY="G Peter Herbison">
<P>In the first session women were taught to contract the pelvic floor muscles correctly and they were provided with explanations about the anatomy of the pelvic floor muscles and lower urinary tract, physiology and continence mechanisms</P>
<P>1. Vaginal cones (n = 15). 12 sessions, 2 x 40-min sessions/week. 5 cones used (Femcone) with weighs varying from 20-100 g. A test was performed in each to determine the weight of the cone for proper pelvic floor training. The selected cone was used during all exercises for that session. It is unclear, but it seems that the same exercises were done with the cone inserted as were done in the pelvic floor muscle training group .</P>
<P>2. PFMT (n = 15). 100 contractions/session on average, with some held for 3 s with 6 s of rest, and some held for 5-10 s followed by 10-20 s of rest. Contractions were carried out in the supine, sitting and standing positions. The degree of difficulty progressed with each session</P>
<P>3. Control (n = 15). No treatment during the 6 weeks, but referred for physiotherapy treatment thereafter</P>
<P>At the end of treatment the women in both of the active treatment groups were instructed about the importance of exercises and received a booklet consisting of written instructions and illustrations for continuation of exercises at home twice a week. The vaginal cones group carried out the exercises at home without the vaginal cone</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:26:34 +0100" MODIFIED_BY="G Peter Herbison">
<P>Primary outcomes were 1-h pad weight test and pelvic floor muscle strength measured with a perineometer (Perina Stim). Secondary outcomes were quality of life, satisfaction with treatment and continuity of training</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:26:37 +0100" MODIFIED_BY="G Peter Herbison">
<P>One published report included information about the 3 month and 12 month follow-up of the active treatment groups. Data were reported as median, minimum and maximum</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:26:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pieber-1995">
<CHAR_METHODS MODIFIED="2013-06-18 13:26:47 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel RCT. Method of group allocation: not stated. No attempt at blinding assessment. Assessments at 6 and 12 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:26:48 +0100" MODIFIED_BY="[Empty name]">
<P>46 premenopausal women with urodynamically-proven GSI. Mean age was 44.3 y (SD 5.7) in the PFMT group and 41.7 y (SD 6.4) in the PFMT + cones group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:26:49 +0100" MODIFIED_BY="[Empty name]">
<P>1. PFMT (n = 25): 1 teaching session, then personalised programme. Asked to perform 100 contractions/day, throughout the day. Visit to physiotherapist at intervals of 2-4 weeks<BR/>2. PFMT + cones (n = 21): as above, with the addition of holding a cone for 15 min daily. Femcon cones, 5 conical weights, 20-70 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:26:50 +0100" MODIFIED_BY="[Empty name]">
<P>Urodynamic measures<BR/>Subjective outcome on an ordinal scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:26:50 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: at 6 weeks 9/25 in PFMT, and 8/21 in the PFMT + cones group<BR/>1 publication from this study was translated from German</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:27:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santos-2009">
<CHAR_METHODS MODIFIED="2013-06-18 13:26:55 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed RCT of 45 patients with SUI. Comparing electrical stimulation of the pelvic floor with cones after 4 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:26:56 +0100" MODIFIED_BY="[Empty name]">
<P>45 patients with urodynamically confirmed SUI. 24 in the electrical stimulation group and 21 in the cones group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:27:07 +0100" MODIFIED_BY="[Empty name]">
<P>1. Electrical stimulation of pelvic floor: participants had 2 x 20-min weekly sessions for 4 consecutive months, under supervision by physiotherapist. Electrode was 10 cm in length and 3.5 cm wide with a double metallic ring and a cylindrical shape, positioned in the middle third of the vagina. Intensity varied from 10-100 mA and 50 Hz with a pulse duration of 1 ms</P>
<P>2. Cones: participants attended 2 x 45-min sessions/week. The cones (Quark brand) varied in weight from 20-100 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:27:09 +0100" MODIFIED_BY="[Empty name]">
<P>Assessment of clinical data: 7-days voiding diary, 1-h pad test and a questionnaire (I-QOL). Measured at baseline and after 4 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:27:10 +0100" MODIFIED_BY="G Peter Herbison">
<P>No participants were lost to follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:27:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seo-2004">
<CHAR_METHODS MODIFIED="2013-06-18 13:27:25 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel study. Multicentred, but number of centres not stated. Method of group allocation: not stated. No attempt at blinding outcome assessment. Outcome may have been measured at 6 weeks (unclear)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:27:27 +0100" MODIFIED_BY="[Empty name]">
<P>120 women with SUI (no further details given)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:27:42 +0100" MODIFIED_BY="[Empty name]">
<P>1. New vaginal cone (n = 60): each cone weighed 150 g; advised to start lying down, and progress to sitting with the cone in place while contracting the pelvic floor. Contract for 5 s, relax for 10 s and repeat for at least 5 min daily for 6 weeks. PFM awareness and compliance were assessed at the hospital once a week<BR/>2. FES-biofeedback (n = 60): 2 x 20-min sessions/week of simultaneous electrical stimulation of 35 Hz and 50 Hz</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:27:47 +0100" MODIFIED_BY="[Empty name]">
<P>Improvement in degree of incontinence<BR/>Unspecified pad test<BR/>Urodynamics<BR/>Vaginal pressure<BR/>Duration of PFM contraction<BR/>Bladder diary (frequency, leakage episodes)<BR/>Difficulty in exercising due to incontinence, social life, daily life, avoiding places, difficulty in personal relationships and QoL scored on a five point Likert scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:27:47 +0100" MODIFIED_BY="[Empty name]">
<P>No withdrawals. Badly reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:28:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Terry-1996">
<CHAR_METHODS MODIFIED="2013-06-18 13:28:00 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel study. Method of group allocation: not stated. No attempt at blinding assessment. Duration of treatment: 6 weeks; outcome measured at 6 weeks and 6 months after entry</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:28:02 +0100" MODIFIED_BY="[Empty name]">
<P>60 women with urodynamically proven SUI, who were able to retain cones</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:28:04 +0100" MODIFIED_BY="[Empty name]">
<P>1. Cones (n = 30): no details of treatment. Used Enhance, 1 cylindrical weight of 75 g<BR/>2. Supervised physiotherapy (n = 30): 12 sessions with a combination of interferential therapy and PFMT with no further details provided</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:28:06 +0100" MODIFIED_BY="[Empty name]">
<P>Stress pad test with full bladder<BR/>Willingness to continue with treatment (at 6 weeks)<BR/>Other outcomes measured but not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:28:09 +0100" MODIFIED_BY="[Empty name]">
<P>Droupouts: 19/30 women in PFMT + electrostimulation group, and 7/30 women in the cones group<BR/>Only abstract available. Follow-up unclear, but used last result carried forward for those with no measurements</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-18 13:28:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-2006">
<CHAR_METHODS MODIFIED="2013-06-18 13:28:19 +0100" MODIFIED_BY="[Empty name]">
<P>3-armed parallel study in women after completing an RCT of nurse-led therapy. Allocation clearly concealed, with self-assessment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-18 13:28:20 +0100" MODIFIED_BY="[Empty name]">
<P>283 women with urodynamically proven stress or mixed incontinence remaining after an 8-week nurse-led RCT of lifestyle interventions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-18 13:28:24 +0100" MODIFIED_BY="[Empty name]">
<P>3 months of therapy.<BR/>1. Pelvic floor muscle training (n = 79): taught to do correct contractions and an individualized exercise programme. Maximum and quick contractions, reinforced at 2-week intervals<BR/>2. Vaginal cones (n = 80): Femina cones, 9 weights. Held heaviest cone possible during prescribed exercise, increasing weight when able to hold it for &gt; 15 min <BR/>3. Control (n = 79): leaflet about the pelvic floor muscles and 3 steps to exercising them</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-18 13:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes measured at 3 months<BR/>Primary outcome: frequency of incontinence episodes from 3-day diary<BR/>Secondary outcomes: 24-h and 1-h pad tests; participants' perception of severity; assessment of pelvic floor function; voiding frequency; pad usage; blind assessment for urinary dysfunction (Leicester Urinary Symptom Questionnaire); and impact on QoL (Leicester Impact Scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-18 13:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 7/238; 3 from control group, 3 from PFMT group, and 1 from vaginal cones group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-08 11:17:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-1998">
<CHAR_METHODS MODIFIED="2013-07-08 11:16:59 +0100" MODIFIED_BY="[Empty name]">
<P>2-armed parallel study in women who had incontinence 3 months postpartum. Group allocation: blinded. Blinding of assessors: for some outcomes. Outcomes measured at 12 months postpartum</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-08 11:17:00 +0100" MODIFIED_BY="[Empty name]">
<P>230 women with symptoms of incontinence 3 months postpartum</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-08 11:17:05 +0100" MODIFIED_BY="[Empty name]">
<P>1. No extra intervention (n = 117): told to continue as normal<BR/>2. Factorial design, PFMT, cones and both (n = 113):<BR/>PFMT (n = 39): 1 training session with physiotherapist plus 3 follow-up visits, fast and slow contractions with aim of 100/day<BR/>Cones (n = 36): training session and 3 follow-up visits. Held cone for 2 sessions of 15 min daily. Femina cones, 9 conical weights, 20-100 g.<BR/>Both (n = 38): both cones and PFMT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-08 11:17:12 +0100" MODIFIED_BY="[Empty name]">
<P>'Yes' or 'no' to incontinence, (urinary and faecal)<BR/>"Home" pad test<BR/>Pelvic floor muscle strength<BR/>Teaching time<BR/>Sexual satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-08 11:17:13 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 26/117 in controls, 59/113 in intervention (20/39 PFMT, 15/36 cones and 24/38 PFMT + cones)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-07-08 11:17:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wise-1993">
<CHAR_METHODS MODIFIED="2013-07-08 11:17:28 +0100" MODIFIED_BY="[Empty name]">
<P>3-armed parallel study. Method of group allocation: not stated. No mention of blinding of assessment. Duration of treatment: 12 weeks, with women seen at 2, 6 and 12 weeks. Outcome assessment at 12 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-08 11:17:29 +0100" MODIFIED_BY="[Empty name]">
<P>61 women with urodynamically proven GSI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-08 11:17:32 +0100" MODIFIED_BY="[Empty name]">
<P>1. Maximal electrical stimulation (n = 20): CONMAX 20 MHz, 0.75 ms pulse duration, continuous stimulation at maximum tolerable intensity between 0 and 90 mA. Home treatment 20 min daily<BR/>2. Cones (n = 21): instructed to use cones for 15 min twice daily. Femina cones, 5 conical weights, 20-70 g<BR/>3. Cones + PFMT (n = 20): cones as above, with 10 sessions of 10 pelvic floor contractions/day</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-08 11:14:17 +0100" MODIFIED_BY="[Empty name]">
<P>VAS<BR/>40-min pad test with standardised bladder volume</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-08 11:14:17 +0100" MODIFIED_BY="[Empty name]">
<P>Dropouts: 4/20 for the electrostimulation group, 2/21 for the cones group, and 6/20 for the cones + PFMT group<BR/>Only abstract published</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>
<BR/>&lt; - less than<BR/>&gt; - more than<BR/>APFMT - assisted pelvic floor muscle training<BR/>BMI - body mass index<BR/>GSI - genuine stress incontinence<BR/>h - hour(s)<BR/>ICS - International Continence Society<BR/>I-QoL - Urinary Incontinence Quality of Life scale<BR/>min - minute(s)<BR/>PF - pelvic floor<BR/>PFM - pelvic floor muscles<BR/>PFMT - pelvic floor muscle training<BR/>QoL - quality of life<BR/>RCT - randomised controlled trial<BR/>s - second(s)<BR/>SD - standard deviation<BR/>SUI - stress urinary incontinence<BR/>UDI-6 - Urinary Distress Inventory <BR/>USI - urodynamic stress incontinence<BR/>VAS - visual analogue scale<BR/>VWC - vaginal weighted cones<BR/>y - year(s)</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="G Peter Herbison" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:33 +0100" MODIFIED_BY="G Peter Herbison" STUDY_ID="STD-Delgado-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:33 +0100" MODIFIED_BY="G Peter Herbison">
<P>This was a randomised trial of a resistance training device for women with stress urinary incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:34 +0100" MODIFIED_BY="G Peter Herbison" STUDY_ID="STD-Ferreira-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:34 +0100" MODIFIED_BY="G Peter Herbison">
<P>This was a systematic review of randomised trials, and not a trial itself</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jonasson-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:35 +0100" MODIFIED_BY="[Empty name]">
<P>The women in the study were not incontinent. This study looked at using cones to prevent incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lentz-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:35 +0100" MODIFIED_BY="[Empty name]">
<P>All women in this study had sensory urgency, so did not fit the inclusion criterion of stress incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Norton-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:36 +0100" MODIFIED_BY="[Empty name]">
<P>Women recruited for this study were not incontinent, but were 6 weeks postpartum. The aim of the study was to look at changes in pelvic-floor strength</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Parkkinen-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="[Empty name]">
<P>This was not a randomised study; women were allocated to groups on the basis of distance from the hospital. Both groups used vaginal balls</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Salinas-Casado-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women recruited for this study were not incontinent. Although the study had a control group, it was not a randomised controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-08 11:17:37 +0100" MODIFIED_BY="[Empty name]">
<P>Nurse-led service that may have used cones, but did not mention this at all</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2013-07-08 11:15:18 +0100" MODIFIED_BY="G Peter Herbison" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2013-07-08 11:15:05 +0100" MODIFIED_BY="G Peter Herbison" STUDY_ID="STD-Driusso-2010">
<CHAR_STUDY_NAME MODIFIED="2013-04-27 15:59:27 +0100" MODIFIED_BY="G Peter Herbison">
<P>Physiotherapy for women with stress urinary incontinence: effects of kinesiotherapy, vaginal cones and electrical stimulation</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-04-22 22:02:05 +0100" MODIFIED_BY="G Peter Herbison">
<P>RCT: "Participants will be divided into four treatment groups"</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-08 11:14:58 +0100" MODIFIED_BY="G Peter Herbison">
<P>Women with urine loss 35 y and over. Exclusion criteria include presence of prolapse greater than grade II, vaginal or urinary infection, uncontrolled hypertension and neurologic or cognitive dysfunction</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-08 11:14:58 +0100" MODIFIED_BY="G Peter Herbison">
<P>Treatment of individual kinesiotherapy; treatment of group kinesiotherapy; treatment with the use of vaginal cones and treatment with the use of electrical stimulation. The treatment will be 12 sessions lasting 30-60 min and supervised by a physiotherapist. In treatments of kinesiotherapy strengthening the pelvic floor muscles will be accomplished through voluntary contraction in different positions (supine, sitting and standing). In the group treated with vaginal cones, the strengthening will also be accomplished in different positions, but with the introduction of progressively heavier cones. In the group treated with intravaginal electrical stimulation, the electrode is inserted into the vagina of the participant inducing muscle contraction associated with voluntary contraction</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-08 11:15:05 +0100" MODIFIED_BY="G Peter Herbison">
<P>Primary outcomes:</P>
<P>Evaluation of the function of the pelvic floor muscles through the digital evaluation of pelvic floor (PERFECT), classified by the Modified Oxford Scale and evaluation of the pressure of contraction of the pelvic floor with use of perineometer Perina (Quark) at baseline and 12 sessions after randomisation, and 6 weeks, 3 months and 1 year after the end of treatment.</P>
<P>Isometric and isokinetic evaluation for the hip adductors and abductors muscle will be assessed using a BIODEX 2 isokinetic dynamometer at baseline and 12 sessions after randomisation.</P>
<P>Urine loss measured by a 1-h pad test and a 3-day voiding diary at baseline and 12 sessions after randomisation, as well as 6 weeks, 3 months and 1 year after the end of treatment.</P>
<P>Secondary outcomes:</P>
<P>Quality of life and sexual function will be assessed through 2 questionnaires: King's Health Questionnaire (KHQ) and Arizona Sexual Experiences Scale (ASEX) at baseline and 12 sessions after randomisation, and at 6 weeks, 3 months and 1 year after the end of treatment</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-07-08 11:15:05 +0100" MODIFIED_BY="G Peter Herbison">
<P>1 August 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-04-27 15:59:47 +0100" MODIFIED_BY="G Peter Herbison">
<P>Grasiela Nascimento Correia, Av. Renato Toledo Porto, 389, Santa Marta. CEP: 13 564-190 Sao Carlos-SP, Brazil. Tel:+55 16 3376 3718, Fax:+55 16 3376 3718, email: grasiela_n_correia@yahoo.com.br</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-04-22 22:03:15 +0100" MODIFIED_BY="G Peter Herbison">
<P>Trial ID: ACTRN12610000254099</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
<BR/>min - minute(s)<BR/>y - year(s)</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-07-08 11:17:27 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-07-08 11:17:23 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:17:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-14 22:52:28 +0000" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>"The patients were consecutively randomised from the physiotherapists' waiting lists to either conventional pelvic floor training or training with vaginal balls by drawing numbered lots."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:20:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-24 22:18:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>"Randomisation schemes stratified by degree of incontinence were constructed for all sites by using computer generated random numbers"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 02:12:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>"A list of random numbers were generated using a computer."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>"The division of the four groups was undertaken by using computer-generated random numbers prepared by the Biostatistics Center of the Federal University of Sao Paulo"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>No information provided. Unclear how the groups were forced to be equally-sized</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:31 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>"Patients were systematically allocated, in a single-blind study, into two groups. The odd numbers were included in group 1 (n = 51) and submitted to VWC associated to standardized general exercise; the even numbers were included in group G2 (n = 52) and treated with assisted PFMT." Quasi-random method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-20 09:39:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>Computer generated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-24 21:15:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>"Randomization was carried out using prepared random number tables, in the ratio 2:2:1"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:40 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>The earlier paper stated, "They were allocated according to a computer-generated randomization list into three groups" and the follow-up paper stated, "Participants were randomly assigned following simple randomization procedures". "For the allocation, a researcher not involved in data collection or analysis developed a randomization schedule and produced 45 consecutively numbered, sealed, opaque envelopes containing each participant&#8217;s allocation.". Simple randomisation cannot be quite correct as there were exactly 15 in each group, but still low risk</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>". . . according to a random numbers table."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-14 01:56:53 +0000" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>"as pacientes foram divididas em dois grupos, de forma randomizada e estratificada, utilizando tábua de números randômicos gerada por computador" translated roughly as "patients were divided into two groups randomly and stratified by using a random number table generated by computer"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>" . . . divided into two groups". Not enough information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>". . . randomised in blocks of 20 . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>"A statistical programme was used to generate a random allocation sequence . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:17:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>Not clearly stated, but was computer generated random numbers. "Stratified by parity . . . number of incontinent episodes . . . and type of delivery . . . and was blocked to produce even numbers after every six subjects in each of the strata". "Those in the intervention group were further randomised in a similar manner to subgroups doing PFME only, vaginal cones only, and both PFME and cones."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:17:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>"The women were randomized into two groups . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:18:33 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>"The patients were consecutively randomised from the physiotherapists' waiting lists to either conventional pelvic floor training or training with vaginal balls by drawing numbered lots."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:20:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>"We have performed a prospective randomised study . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>". . . randomised to treatment . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>"Participants within each stratum were randomised by using opaque sealed envelopes . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 02:14:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>"A numbered opaque sealed envelope containing the method indicator card was opened by the secretary of the department."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>This was not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:23:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>"The patients included in the study were randomly divided into two equally-sized groups . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:34 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>"Patients were systematically allocated, in a single-blind study, into two groups. The odd numbers were included in group 1 (n = 51) and submitted to VWC associated to standardized general exercise; the even numbers were included in group G2 (n = 52) and treated with assisted PFMT." Alternate allocation, so not hidden.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>". . . were randomised to treatment . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-20 09:40:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>Sealed opaque envelope</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>"The women were randomised into two groups . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>". . . subjects were randomized into three groups . . . "</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>". . . entered into the trial and randomly allocated . . . " no further information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>". . . women with cystometrically proven genuine stress incontinence were randomly allocated to the use of cones or physiotherapy."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:43 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>"Allocation was concealed in sequentially numbered, sealed, opaque envelopes. Immediately after collecting baseline data, the physical therapist opened the allocation envelope, which contained the participant&#8217;s group.". Sealed envelopes should have hidden allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>Patients were randomly assigned to one of the two treatment groups . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:11 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>". . . randomised in blocks of 20 . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>". . . allocation sequence and this was implemented using sealed envelopes numbered sequentially". So this should have hidden the allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-04-27 15:58:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>"The assignment was done by means of a computer programme that used files stored in a computer readable form to produce the next assignment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>". . . were randomised to receive treatment with either . . ."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-07-08 11:17:25 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>Assessor measured outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Patient reported outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:17:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:18:36 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>Impossible to blind participants to treatment group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-03-14 22:55:12 +0000" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>"The tests were carried out blind at baseline and after 2 and 4 months."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:20:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:20:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:21:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:21:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-02-24 23:00:43 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:21:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>Not possible to blind participants, but possibly influenced by almost half of women in the cones group stopping treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>No mention of blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:22:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>There is uncertainty whether these will be affected by knowledge of the treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:22:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>"The investigator responsible for assessing patients outcomes was not involved in administering any of the treatments and was blind to the group assignments"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:23:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:23:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:24:37 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>Study says single-blind without saying who was blinded. Main outcomes were participant reports</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:24:40 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>Although study says single-blind it was unclear who was blinded. A single assessor measured all outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:24:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:24:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-05-08 02:43:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>Not possible to blind treatment provider or participant to treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:25:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>A single physician blinded to assignment assessed the outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:25:28 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:25:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:25:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:25:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:25:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>Not possible to blind, but unlikely to cause bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:25:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:26:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:26:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:26:44 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>These treatments are impossible to blind from the treatment provider and the participant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-03-13 03:48:09 +0000" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>"Only one unblinded experienced physical therapist performed all evaluations of the three groups."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:26:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:26:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:27:13 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>Main outcomes were patient reported and it was impossible to blind them to the treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:27:15 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>No mention of who measures the assessor-measured outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:27:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>No clarity about how these were answered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:27:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>No information provided about these</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:28:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-06-18 13:28:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-06-18 13:28:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>"The patients were interviewed at home by trained interviewers who were independent of the clinical interventions". Urinary diaries were also self-completed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-07-08 11:16:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>Unclear who measured these</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-08 11:17:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-07-08 11:17:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>". . . recorded by a second physiotherapist, blinded to the group allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-07-08 11:17:26 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>Outcome reported on all who were randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:18:38 +0100" MODIFIED_BY="G Peter Herbison" RESULT="NO" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>Drop out was differential with more dropping out of the vaginal ball group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:20:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>Only completers analysed, moderate withdrawal rate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:21:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>Reported that there were no withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:21:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>Reported by group only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:22:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>All who were randomised were in the analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:22:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>Withdrawals and dropouts reported by groups and roughly equal, but 17% is more than desirable</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:23:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>All followed up, except for 2 who refused to be urodynamically tested, but had other outcomes measured</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:24:42 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>There was no loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-02-25 07:58:36 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>Reported by group, high in the cones group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:25:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>Only 7 participants in each arm returned for end of study urodynamic studies</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:25:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>High dropout level in 1 group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-02-24 21:45:07 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>High proportion of dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:25:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>Outcomes reported on all randomised, including those who did not get treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:26:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>Only completers analysed, with approximately 25% withdrawals, some because of lack of compliance</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:26:45 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>No loss to follow-up at either of the outcome measurements</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:26:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>Some outcomes used last observation carried forward</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:27:21 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>All participants completed the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:27:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>According to the report there were no withdrawals</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-18 13:28:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>Used last observation carried forward, which is not optimal</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-08 11:16:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>"The effectiveness of the interventions was analysed by intention-to-treat." Only a small number with no data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-08 11:17:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>There were a large number of dropouts with no outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>Completers analysis only</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-07-08 11:17:26 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:17:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:18:39 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:20:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>Unclear, as only an abstract, no urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>Reported on all outcomes specified, but no urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>No evidence of omitted outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>Does not appear to have any unreported outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>There was no obvious failure to report outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:23:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>Follow up pad tests only for those "whose results were positive prior to treatment". No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:46 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>Some outcomes were not fully reported - just stated that there was no statistical significance in the outcome. No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>No bladder diary results reported, which is unusual</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:17 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>No evidence of unreported outcomes. No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>All outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>Seems to have reported all outcomes (without SD). No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>Some results from urinary diary not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>No urinary diaries kept</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:13:38 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>All likely outcomes measured and reported. Urinary diaries appear to not have been used in this study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>Does not appear to have used, or else not reported urinary diary results</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:22 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>Nothing is likely to have been omitted</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>Seemed to report all outcomes measured, with nothing missing, but reporting was poor</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>Urinary diaries were either not used, or not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:16:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>All outcomes reported and nothing obvious missing</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:17:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>All outcomes were included and reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>No urinary diariesmentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-07-08 11:17:27 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:17:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arvonen-2001">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:18:40 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Arvonen-2002">
<DESCRIPTION>
<P>Unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:20:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bourcier-1994">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burton-1993">
<DESCRIPTION>
<P>Only abstract published</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:21:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-B_x00f8_-1999">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cammu-1998">
<DESCRIPTION>
<P>No reason to suspect other biases</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:22:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Castro-2008">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:23:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delneri-2000">
<DESCRIPTION>
<P>Very large difference in ages between the two groups (16.5 y reported in the results) but this does not match with the mean ages reported in the methods (49.5 y, SD 14.5, and 41.5 y, SD 7.4) with the cones group being younger</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:24:47 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Gameiro-2010">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haken-1991">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-08 03:22:28 +0100" MODIFIED_BY="G Peter Herbison" RESULT="UNKNOWN" STUDY_ID="STD-Harvey-2006">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laycock-1993">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-24 21:47:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laycock-2001">
<DESCRIPTION>
<P>Nothing obvious</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:25:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Olah-1990">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peattie-1988a">
<DESCRIPTION>
<P>Nothing suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-03-13 03:51:03 +0000" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Pereira-2012">
<DESCRIPTION>
<P>Nothing suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:26:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pieber-1995">
<DESCRIPTION>
<P>Unlikely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:27:23 +0100" MODIFIED_BY="G Peter Herbison" RESULT="YES" STUDY_ID="STD-Santos-2009">
<DESCRIPTION>
<P>Nothing likely</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-24 04:03:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Seo-2004">
<DESCRIPTION>
<P>Nothing suggestive of this, but poor reporting</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-18 13:28:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Terry-1996">
<DESCRIPTION>
<P>None suspected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:16:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Williams-2006">
<DESCRIPTION>
<P>Nothing to suspect</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:17:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wilson-1998">
<DESCRIPTION>
<P>No reason to suspect this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-08 11:14:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wise-1993">
<DESCRIPTION>
<P>No reason for this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-06-26 12:02:05 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-06-13 16:36:26 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>CONES versus CONTROL</NAME>
<DICH_OUTCOME CHI2="9.52705828545989" CI_END="0.9898479569678291" CI_START="0.5244043133161177" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7204724409448819" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="55" I2="89.50358053832639" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.004431508958933872" LOG_CI_START="-0.2803337448200832" LOG_EFFECT_SIZE="-0.14238262688950856" METHOD="MH" MODIFIED="2013-06-13 16:35:58 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0020246609270080373" P_Q="1.0" P_Z="0.04308083913029545" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="106" TOTAL_2="109" WEIGHT="100.0" Z="2.0229254022289496">
<NAME>No subjective improvement or cure</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="9.52705828545989" CI_END="0.9898479569678291" CI_START="0.5244043133161177" DF="1" EFFECT_SIZE="0.7204724409448819" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="55" I2="89.50358053832639" ID="CMP-001.01.01" LOG_CI_END="-0.004431508958933872" LOG_CI_START="-0.2803337448200832" LOG_EFFECT_SIZE="-0.14238262688950856" NO="1" P_CHI2="0.0020246609270080373" P_Z="0.04308083913029545" STUDIES="2" TAU2="0.0" TOTAL_1="106" TOTAL_2="109" WEIGHT="100.0" Z="2.0229254022289496">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="0.6293428961173207" CI_START="0.23325537007021577" EFFECT_SIZE="0.3831417624521073" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="29" LOG_CI_END="-0.20111266565893976" LOG_CI_START="-0.6321683490176222" LOG_EFFECT_SIZE="-0.41664050733828095" ORDER="7749" O_E="0.0" SE="0.2532042421649355" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="30" VAR="0.06411238825031929" WEIGHT="51.37795275590551"/>
<DICH_DATA CI_END="1.6608698257858499" CI_START="0.6982867023071593" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="26" LOG_CI_END="0.22033559502916825" LOG_CI_START="-0.1559662282863658" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="7750" O_E="0.0" SE="0.2210415537396117" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="79" VAR="0.04885936847962165" WEIGHT="48.62204724409449"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.863213190187455" CI_END="0.9382917765826406" CI_START="0.7558902404339541" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8421672022812656" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="190" I2="79.81593911348476" I2_Q="51.58783836614483" ID="CMP-001.02" LOG_CI_END="-0.027662089920049395" LOG_CI_START="-0.12154126195187931" LOG_EFFECT_SIZE="-0.07460167593596437" METHOD="MH" MODIFIED="2013-06-13 16:36:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0019373566548772647" P_Q="0.15065599800583018" P_Z="0.0018394773194132519" Q="2.0655966729250297" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="151" TOTAL_2="224" WEIGHT="100.0" Z="3.114995474635068">
<NAME>No subjective cure</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.135414110418445" CI_END="0.9783511886572387" CI_START="0.8069847078720291" DF="2" EFFECT_SIZE="0.8885462555066079" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="121" I2="75.41612543805554" ID="CMP-001.02.01" LOG_CI_END="-0.0095052230053139" LOG_CI_START="-0.09313469495540064" LOG_EFFECT_SIZE="-0.05131995898035729" MODIFIED="2011-02-24 02:34:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.01711665753809055" P_Z="0.016150432399369686" STUDIES="3" TAU2="0.0" TOTAL_1="130" TOTAL_2="133" WEIGHT="82.19798126103291" Z="2.405498180105845">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="1.0210306875007513" CI_START="0.6958658948753949" EFFECT_SIZE="0.842911877394636" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.00903879518383213" LOG_CI_START="-0.15747444821598156" LOG_EFFECT_SIZE="-0.07421782651607473" ORDER="7751" O_E="0.0" SE="0.09781070342689875" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="30" VAR="0.009566933704864743" WEIGHT="18.90191463359435"/>
<DICH_DATA CI_END="0.936483149335603" CI_START="0.3579136000892902" EFFECT_SIZE="0.5789473684210527" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="19" LOG_CI_END="-0.028500032721635905" LOG_CI_START="-0.44622179886757196" LOG_EFFECT_SIZE="-0.23736091579460392" MODIFIED="2011-02-24 02:34:34 +0000" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.2453718331902136" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.06020733652312601" WEIGHT="13.072013760014485"/>
<DICH_DATA CI_END="1.0828647589539526" CI_START="0.8983489250618635" EFFECT_SIZE="0.9863013698630136" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="73" LOG_CI_END="0.03457422014554135" LOG_CI_START="-0.04655494752391628" LOG_EFFECT_SIZE="-0.005990363689187465" ORDER="7752" O_E="0.0" SE="0.04765567468489621" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="79" VAR="0.0022710633296726575" WEIGHT="50.22405286742407"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9981517547680083" CI_START="0.39513858390849005" DF="0" EFFECT_SIZE="0.6280193236714976" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="69" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-8.03425397959231E-4" LOG_CI_START="-0.40325056090220274" LOG_EFFECT_SIZE="-0.20202699315008096" NO="2" P_CHI2="1.0" P_Z="0.04909225898087348" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="91" WEIGHT="17.802018738967096" Z="1.9677895333157556">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="0.9981517547680083" CI_START="0.39513858390849005" EFFECT_SIZE="0.6280193236714976" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="69" LOG_CI_END="-8.03425397959231E-4" LOG_CI_START="-0.40325056090220274" LOG_EFFECT_SIZE="-0.20202699315008096" ORDER="7753" O_E="0.0" SE="0.2363994395406423" STUDY_ID="STD-Wilson-1998" TOTAL_1="21" TOTAL_2="91" VAR="0.0558846950151298" WEIGHT="17.802018738967096"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="12.19901593578221" CI_END="-0.3765018976550107" CI_START="-1.0083674300843721" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6924346638696914" ESTIMABLE="YES" I2="83.60523495888229" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2013-06-13 16:36:13 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0022439796339862594" P_Q="1.0" P_Z="1.741563259090163E-5" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="132" TOTAL_2="129" UNITS="" WEIGHT="100.0" Z="4.295682967905561">
<NAME>Leakage episodes per day</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="12.19901593578221" CI_END="-0.3765018976550107" CI_START="-1.0083674300843721" DF="2" EFFECT_SIZE="-0.6924346638696914" ESTIMABLE="YES" I2="83.60523495888229" ID="CMP-001.03.01" MODIFIED="2011-02-24 02:38:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0022439796339862594" P_Z="1.741563259090163E-5" STUDIES="3" TAU2="0.0" TOTAL_1="132" TOTAL_2="129" WEIGHT="100.0" Z="4.295682967905561">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="0.8624422924404459" CI_START="-0.6624422924404462" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.17" MEAN_2="1.07" ORDER="7754" SD_1="1.8" SD_2="1.09" SE="0.3890083177315979" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="30" WEIGHT="17.170201157100287"/>
<CONT_DATA CI_END="-0.6752075985161272" CI_START="-1.4247924014838729" EFFECT_SIZE="-1.05" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="1.26" MODIFIED="2011-02-24 02:38:39 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="0.26" SD_2="0.9" SE="0.19122412679017955" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="24" WEIGHT="71.05715010586623"/>
<CONT_DATA CI_END="1.230783603207592" CI_START="-0.6107836032075921" EFFECT_SIZE="0.30999999999999994" ESTIMABLE="YES" MEAN_1="-0.28" MEAN_2="-0.59" ORDER="7755" SD_1="2.68" SD_2="3.12" SE="0.46979618527208433" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="75" WEIGHT="11.772648737033482"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.1789942303208" CI_END="1.0624106503351607" CI_START="0.6455873377626586" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8281780384437705" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="99" I2="28.21239191398201" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.02629241571238977" LOG_CI_START="-0.19004499624406265" LOG_EFFECT_SIZE="-0.08187629026583639" METHOD="MH" MODIFIED="2013-06-13 16:36:19 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2427735243129332" P_Q="0.3836995012295541" P_Z="0.13792614258605693" Q="0.758815492317491" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="135" TOTAL_2="178" WEIGHT="100.00000000000001" Z="1.4835582866368897">
<NAME>No improvement on pad test</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.9378826705299703" CI_END="1.182329812598527" CI_START="0.6608836206795803" DF="2" EFFECT_SIZE="0.8839583742391517" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="51" I2="49.211285166837264" ID="CMP-001.04.01" LOG_CI_END="0.07273864051463569" LOG_CI_START="-0.1798750115379897" LOG_EFFECT_SIZE="-0.05356818551167704" MODIFIED="2011-02-24 02:51:38 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.13960474651911337" P_Z="0.4058361551868285" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="112" WEIGHT="71.60704601602829" Z="0.8312433905842515">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="2.384817674811927" CI_START="0.5176781077538471" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.377455181761929" LOG_CI_START="-0.28594020064057873" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="7756" O_E="0.0" SE="0.38968173148333735" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="30" VAR="0.15185185185185185" WEIGHT="11.768132243356701"/>
<DICH_DATA CI_END="0.9215470921862061" CI_START="0.41584413634186085" EFFECT_SIZE="0.6190476190476191" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" LOG_CI_END="-0.03548246689738357" LOG_CI_START="-0.3810694179567814" LOG_EFFECT_SIZE="-0.20827594242708247" MODIFIED="2011-02-24 02:51:38 +0000" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.20299948573528756" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.04120879120879122" WEIGHT="28.9844738586378"/>
<DICH_DATA CI_END="1.6582088284943093" CI_START="0.6600400991631197" EFFECT_SIZE="1.046176046176046" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="21" LOG_CI_END="0.21963922304883482" LOG_CI_START="-0.18042967913046104" LOG_EFFECT_SIZE="0.019604771959186917" ORDER="7757" O_E="0.0" SE="0.23500245351312324" STUDY_ID="STD-Williams-2006" TOTAL_1="66" TOTAL_2="58" VAR="0.055226153157187645" WEIGHT="30.854439914033787"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1166385636523053" CI_START="0.4232849064911697" DF="0" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="48" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.04791262234317213" LOG_CI_START="-0.37336721733857153" LOG_EFFECT_SIZE="-0.16272729749769974" NO="2" P_CHI2="1.0" P_Z="0.12998875340293564" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="66" WEIGHT="28.392953983971722" Z="1.514146238936901">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.1166385636523053" CI_START="0.4232849064911696" EFFECT_SIZE="0.6875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="48" LOG_CI_END="0.04791262234317213" LOG_CI_START="-0.3733672173385716" LOG_EFFECT_SIZE="-0.16272729749769974" ORDER="7758" O_E="0.0" SE="0.2474618631978951" STUDY_ID="STD-Wilson-1998" TOTAL_1="18" TOTAL_2="66" VAR="0.06123737373737374" WEIGHT="28.392953983971722"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="48.47132028643181" CI_END="0.7079731253562858" CI_START="-3.082650325372248" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.187338600007981" ESTIMABLE="YES" I2="93.81077308752457" I2_Q="88.56842376773066" ID="CMP-001.05" MODIFIED="2013-06-13 16:36:26 +0100" MODIFIED_BY="G Peter Herbison" NO="5" P_CHI2="1.6903278776680963E-10" P_Q="0.003099947283129678" P_Z="0.21950679346810198" Q="8.7477000518719" RANDOM="NO" SCALE="49.33" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="142" TOTAL_2="199" UNITS="" WEIGHT="100.0" Z="1.2278407094340065">
<NAME>Pelvic floor muscle strength</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.14721246952268285" CI_END="2.427682357304848" CI_START="-1.8408451425956702" DF="1" EFFECT_SIZE="0.2934186073545888" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.01" NO="1" P_CHI2="0.701213726350294" P_Z="0.7875788950036278" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="105" WEIGHT="78.86151621475122" Z="0.2694558734000409">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="6.867256673661644" CI_START="-4.267256673661646" EFFECT_SIZE="1.299999999999999" ESTIMABLE="YES" MEAN_1="-15.1" MEAN_2="-16.4" ORDER="7759" SD_1="11.8" SD_2="9.9" SE="2.840489273055758" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="30" WEIGHT="11.589876538841944"/>
<CONT_DATA CI_END="2.4308121520745134" CI_START="-2.190812152074513" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="0.13" ORDER="7760" SD_1="6.42" SD_2="8.07" SE="1.1790074564134365" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="75" WEIGHT="67.27163967590927"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="39.57640776503722" CI_END="-2.5892724729366066" CI_START="-10.833951037673568" DF="1" EFFECT_SIZE="-6.711611755305087" ESTIMABLE="YES" I2="97.47324212460883" ID="CMP-001.05.02" MODIFIED="2013-03-15 01:43:19 +0000" MODIFIED_BY="G Peter Herbison" NO="2" P_CHI2="3.1548752499332977E-10" P_Z="0.0014176548798403958" STUDIES="2" TAU2="0.0" TOTAL_1="34" TOTAL_2="94" WEIGHT="21.138483785248784" Z="3.191032182837636">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="-22.62247461380364" CI_START="-40.037525386196364" EFFECT_SIZE="-31.330000000000002" ESTIMABLE="YES" MEAN_1="-43.24" MEAN_2="-11.91" MODIFIED="2013-03-15 01:43:19 +0000" MODIFIED_BY="G Peter Herbison" ORDER="76" SD_1="16.28" SD_2="5.57" SE="4.4426966285504275" STUDY_ID="STD-Pereira-2012" TOTAL_1="15" TOTAL_2="15" WEIGHT="4.737746289836156"/>
<CONT_DATA CI_END="5.0800334874742505" CI_START="-4.28003348747425" EFFECT_SIZE="0.40000000000000036" ESTIMABLE="YES" MEAN_1="-12.7" MEAN_2="-13.1" ORDER="7761" SD_1="9.6" SD_2="8.2" SE="2.387816064167381" STUDY_ID="STD-Wilson-1998" TOTAL_1="19" TOTAL_2="79" WEIGHT="16.400737495412628"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-06-13 16:37:06 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>CONES versus PELVIC FLOOR MUSCLE TRAINING</NAME>
<DICH_OUTCOME CHI2="6.642075895492637" CI_END="1.2436165221547926" CI_START="0.7494362338422027" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9654073144054928" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="73" I2="24.72232960492008" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.09468648325937404" LOG_CI_START="-0.1252653134075348" LOG_EFFECT_SIZE="-0.015289415074080383" METHOD="MH" MODIFIED="2013-06-13 16:36:36 +0100" MODIFIED_BY="G Peter Herbison" NO="1" P_CHI2="0.24864921336187507" P_Q="0.44186412948307996" P_Z="0.7852496812895651" Q="0.5914369951519397" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="178" TOTAL_2="180" WEIGHT="100.0" Z="0.2724842746818969">
<NAME>No subjective improvement or cure</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.423805972610721" CI_END="1.3604428251947156" CI_START="0.7508617723586819" DF="3" EFFECT_SIZE="1.0106950632700036" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="55" I2="44.688286875498875" ID="CMP-002.01.01" LOG_CI_END="0.1336802945728094" LOG_CI_START="-0.12444000577504781" LOG_EFFECT_SIZE="0.004620144398880767" NO="1" P_CHI2="0.14326763718867008" P_Z="0.9440634960108163" STUDIES="4" TAU2="0.0" TOTAL_1="153" TOTAL_2="151" WEIGHT="76.80445643215486" Z="0.07016353702500203">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="19.103048297336237" CI_START="1.121992164493104" EFFECT_SIZE="4.62962962962963" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.2811026736918014" LOG_CI_START="0.0499898240063368" LOG_EFFECT_SIZE="0.6655462488490691" ORDER="7762" O_E="0.0" SE="0.7231617820121323" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.5229629629629629" WEIGHT="2.897611043945589"/>
<DICH_DATA CI_END="1.6258994865776615" CI_START="0.5303186974824095" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.21109369391859567" LOG_CI_START="-0.27546306066139814" LOG_EFFECT_SIZE="-0.03218468337140124" ORDER="7763" O_E="0.0" SE="0.2858058461350672" STUDY_ID="STD-Cammu-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.0816849816849817" WEIGHT="19.53204481474434"/>
<DICH_DATA CI_END="2.0706563314350097" CI_START="0.2970787622521598" EFFECT_SIZE="0.7843137254901961" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.3161080246556224" LOG_CI_START="-0.5271283941955703" LOG_EFFECT_SIZE="-0.10551018476997398" ORDER="7764" O_E="0.0" SE="0.4953212465207827" STUDY_ID="STD-Peattie-1988a" TOTAL_1="17" TOTAL_2="16" VAR="0.24534313725490198" WEIGHT="8.62453926884815"/>
<DICH_DATA CI_END="1.2769259912140591" CI_START="0.5781602738537311" EFFECT_SIZE="0.8592251630226314" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="33" LOG_CI_END="0.10616572691199082" LOG_CI_START="-0.23795175258032297" LOG_EFFECT_SIZE="-0.06589301283416608" ORDER="7765" O_E="0.0" SE="0.2021363108627808" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="80" VAR="0.040859088169214755" WEIGHT="45.75026130461679"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3492628018241576" CI_END="1.290827114260977" CI_START="0.5151437723120579" DF="1" EFFECT_SIZE="0.8154517453798769" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="18" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.11086807933044762" LOG_CI_START="-0.2880715460893085" LOG_EFFECT_SIZE="-0.08860173337943045" MODIFIED="2013-03-14 23:08:45 +0000" MODIFIED_BY="G Peter Herbison" NO="2" P_CHI2="0.5545309404093313" P_Z="0.38397866423546856" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="29" WEIGHT="23.19554356784514" Z="0.8705889078267744">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="2.02124274087954" CI_START="0.422046035003542" EFFECT_SIZE="0.9236111111111112" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3056184731857647" LOG_CI_START="-0.3746401754420923" LOG_EFFECT_SIZE="-0.03451085112816384" ORDER="7766" O_E="0.0" SE="0.39958729753862154" STUDY_ID="STD-Arvonen-2001" TOTAL_1="18" TOTAL_2="19" VAR="0.15967000835421888" WEIGHT="10.859515263796082"/>
<DICH_DATA CI_END="1.1693939452866606" CI_START="0.44359979451153814" EFFECT_SIZE="0.7202380952380952" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.06796084088197298" LOG_CI_START="-0.35300866370079853" LOG_EFFECT_SIZE="-0.14252391140941278" MODIFIED="2013-03-14 23:08:45 +0000" MODIFIED_BY="G Peter Herbison" ORDER="71" O_E="0.0" SE="0.24727957082457527" STUDY_ID="STD-Arvonen-2002" TOTAL_1="7" TOTAL_2="10" VAR="0.061147186147186144" WEIGHT="12.336028304049057"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.444511849319218" CI_END="1.12633587387979" CI_START="0.9071674715209073" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0108289997773217" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="128" I2="57.64736109375173" I2_Q="42.45142736588604" ID="CMP-002.02" LOG_CI_END="0.0516679166445172" LOG_CI_START="-0.04231253075302913" LOG_EFFECT_SIZE="0.004677692945744032" METHOD="MH" MODIFIED="2013-06-13 16:36:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05090000887233381" P_Q="0.1874353747027543" P_Z="0.8453093805519383" Q="1.7376625591704329" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="169" TOTAL_2="169" WEIGHT="100.0" Z="0.19510674737721556">
<NAME>No subjective cure</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="8.230409037948622" CI_END="1.1825914004905667" CI_START="0.9409534021809913" DF="2" EFFECT_SIZE="1.0548760124685659" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="100" I2="75.69987116340833" ID="CMP-002.02.01" LOG_CI_END="0.07283471659351733" LOG_CI_START="-0.026431883136768402" LOG_EFFECT_SIZE="0.023201416728374464" MODIFIED="2011-02-24 03:03:09 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.016322681193852606" P_Z="0.35956294748684026" STUDIES="3" TAU2="0.0" TOTAL_1="130" TOTAL_2="131" WEIGHT="77.77899493493422" Z="0.9161982238028691">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="2.378508549272562" CI_START="1.0323011930829116" EFFECT_SIZE="1.566951566951567" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="13" LOG_CI_END="0.3763047167797697" LOG_CI_START="0.013806429277069857" LOG_EFFECT_SIZE="0.19505557302841978" ORDER="7767" O_E="0.0" SE="0.21293328847454865" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.04534058534058535" WEIGHT="10.544237904337015"/>
<DICH_DATA CI_END="2.0239539393627033" CI_START="0.57986058293434" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3062006247150783" LOG_CI_START="-0.2366764121966545" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2011-02-24 03:03:09 +0000" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.31888865876662453" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="26" VAR="0.1016899766899767" WEIGHT="8.247937205170286"/>
<DICH_DATA CI_END="1.0446550434661444" CI_START="0.8810299949874991" EFFECT_SIZE="0.9593604263824117" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="76" LOG_CI_END="0.018972905326184793" LOG_CI_START="-0.05500930562222626" LOG_EFFECT_SIZE="-0.018018200148020747" ORDER="7768" O_E="0.0" SE="0.04345751692894713" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="80" VAR="0.0018885557776297263" WEIGHT="58.98681982542691"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6932936947694338" CI_END="1.1421158595378638" CI_START="0.6425402303641125" DF="1" EFFECT_SIZE="0.8566535983056193" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="28" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.0577101622335812" LOG_CI_START="-0.19209967534583583" LOG_EFFECT_SIZE="-0.0671947565561273" NO="2" P_CHI2="0.405046732005635" P_Z="0.2917014629536603" STUDIES="2" TAU2="0.0" TOTAL_1="39" TOTAL_2="38" WEIGHT="22.221005065065782" Z="1.0543964487233426">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.0152797296901375" CI_START="0.6034396678953613" EFFECT_SIZE="0.7827260458839406" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.006585715474397073" LOG_CI_START="-0.21936614430717882" LOG_EFFECT_SIZE="-0.10639021441639092" ORDER="7769" O_E="0.0" SE="0.1327252409154422" STUDY_ID="STD-Arvonen-2001" TOTAL_1="18" TOTAL_2="19" VAR="0.01761598957606217" WEIGHT="14.840038532029872"/>
<DICH_DATA CI_END="1.9306585083156464" CI_START="0.5234535268490754" EFFECT_SIZE="1.0052910052910053" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.2857054632824552" LOG_CI_START="-0.2811218697232855" LOG_EFFECT_SIZE="0.002291796779584843" ORDER="7770" O_E="0.0" SE="0.33295718124812246" STUDY_ID="STD-Wilson-1998" TOTAL_1="21" TOTAL_2="19" VAR="0.11086048454469508" WEIGHT="7.3809665330359095"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="13.177583340981128" CI_END="0.19706406770417134" CI_START="-0.19850846823905927" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.222002674439759E-4" ESTIMABLE="YES" I2="77.23406543997893" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-06-13 16:36:51 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.004267911151087045" P_Q="1.0" P_Z="0.9942898705438012" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="162" TOTAL_2="162" UNITS="" WEIGHT="100.0" Z="0.007156647063174917">
<NAME>Leakage episodes per day</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="13.177583340981128" CI_END="0.19706406770417134" CI_START="-0.19850846823905927" DF="3" EFFECT_SIZE="-7.222002674439759E-4" ESTIMABLE="YES" I2="77.23406543997893" ID="CMP-002.03.01" MODIFIED="2013-03-26 22:48:27 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.004267911151087045" P_Z="0.9942898705438012" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="162" WEIGHT="100.0" Z="0.007156647063174917">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="1.5680950696908371" CI_START="0.23190493030916282" EFFECT_SIZE="0.8999999999999999" ESTIMABLE="YES" MEAN_1="1.17" MEAN_2="0.27" ORDER="7771" SD_1="1.8" SD_2="0.36" SE="0.34087109506127955" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="29" WEIGHT="8.76426979154839"/>
<CONT_DATA CI_END="1.1377036439282384" CI_START="-0.3377036439282385" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="0.8" ORDER="7772" SD_1="1.9" SD_2="0.8" SE="0.3763863263545405" STUDY_ID="STD-Cammu-1998" TOTAL_1="30" TOTAL_2="30" WEIGHT="7.188336752032809"/>
<CONT_DATA CI_END="0.041922220744523675" CI_START="-0.4019222207445237" EFFECT_SIZE="-0.18000000000000002" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.39" MODIFIED="2013-03-26 22:48:27 +0000" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="0.26" SD_2="0.51" SE="0.11322770341445958" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="26" WEIGHT="79.43112110996255"/>
<CONT_DATA CI_END="1.6705564479846853" CI_START="-0.1705564479846854" EFFECT_SIZE="0.75" ESTIMABLE="YES" MEAN_1="-0.28" MEAN_2="-1.03" ORDER="7773" SD_1="2.68" SD_2="3.16" SE="0.4696802876205467" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="77" WEIGHT="4.6162723464562525"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.24154880738201" CI_END="1.3072077382159994" CI_START="0.7642831527748264" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.999538319173094" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="67" I2="27.19815000518155" I2_Q="61.53176286979534" ID="CMP-002.04" LOG_CI_END="0.11634461006851264" LOG_CI_START="-0.1167457135375811" LOG_EFFECT_SIZE="-2.0055173453423737E-4" METHOD="MH" MODIFIED="2013-06-13 16:36:59 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.22093569185510153" P_Q="0.10689429319635113" P_Z="0.9973089640321205" Q="2.5995472488517426" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="193" TOTAL_2="191" WEIGHT="100.0" Z="0.0033727198164468708">
<NAME>No improvement on pad test</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.715446365005807" CI_END="1.4901579955572535" CI_START="0.8183794724950896" DF="4" EFFECT_SIZE="1.1043164013716744" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="53" I2="30.014215084040316" ID="CMP-002.04.01" LOG_CI_END="0.17323231737937375" LOG_CI_START="-0.0870452726169088" LOG_EFFECT_SIZE="0.043093522381232485" MODIFIED="2011-02-24 03:07:28 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22143067279229067" P_Z="0.5163300664907119" STUDIES="5" TAU2="0.0" TOTAL_1="157" TOTAL_2="157" WEIGHT="78.04043775301646" Z="0.6490128622705685">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="17.452193145855937" CI_START="0.9947810550809514" EFFECT_SIZE="4.166666666666667" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.2418500107389898" LOG_CI_START="-0.0022724941622017476" LOG_EFFECT_SIZE="0.619788758288394" ORDER="7774" O_E="0.0" SE="0.7308037178846822" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.5340740740740741" WEIGHT="3.106189238133329"/>
<DICH_DATA CI_END="1.6784484694850748" CI_START="0.6029021510885071" EFFECT_SIZE="1.005952380952381" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.22490801239260053" LOG_CI_START="-0.21975316661697922" LOG_EFFECT_SIZE="0.0025774228878106755" MODIFIED="2011-02-24 03:07:28 +0000" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.2611961776585623" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="26" VAR="0.06822344322344323" WEIGHT="20.10049569209834"/>
<DICH_DATA CI_END="1.6370124148727996" CI_START="0.30920890642296406" EFFECT_SIZE="0.7114624505928854" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" LOG_CI_END="0.21405197305293433" LOG_CI_START="-0.509748005197958" LOG_EFFECT_SIZE="-0.14784801607251186" ORDER="7775" O_E="0.0" SE="0.42516369009225025" STUDY_ID="STD-Haken-1991" TOTAL_1="23" TOTAL_2="30" VAR="0.18076416337285903" WEIGHT="14.278485540489894"/>
<DICH_DATA CI_END="1.6911459827934752" CI_START="0.2672421474398378" EFFECT_SIZE="0.6722689075630253" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.2281810983045421" LOG_CI_START="-0.5730950471057165" LOG_EFFECT_SIZE="-0.17245697440058713" ORDER="7776" O_E="0.0" SE="0.4706735741948746" STUDY_ID="STD-Peattie-1988a" TOTAL_1="17" TOTAL_2="16" VAR="0.22153361344537814" WEIGHT="10.786250844876005"/>
<DICH_DATA CI_END="1.9395598873230984" CI_START="0.7377075893145929" EFFECT_SIZE="1.1961722488038278" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="19" LOG_CI_END="0.28770319374913056" LOG_CI_START="-0.13211574862716338" LOG_EFFECT_SIZE="0.07779372256098362" ORDER="7777" O_E="0.0" SE="0.24660372488911558" STUDY_ID="STD-Wilson-1998" TOTAL_1="66" TOTAL_2="60" VAR="0.06081339712918661" WEIGHT="29.76901643741889"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8936176180022275" CI_END="1.164746290219852" CI_START="0.33771212297772063" DF="1" EFFECT_SIZE="0.6271753681392235" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" I2="47.191027877370345" ID="CMP-002.04.02" LOG_CI_END="0.06623133587096633" LOG_CI_START="-0.4714533490541698" LOG_EFFECT_SIZE="-0.20261100659160178" NO="2" P_CHI2="0.16879467758118305" P_Z="0.13964559182786768" STUDIES="2" TAU2="0.0" TOTAL_1="36" TOTAL_2="34" WEIGHT="21.959562246983538" Z="1.4771120953398111">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.6365538616705486" CI_START="0.027232773866100714" EFFECT_SIZE="0.2111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.21393030322261736" LOG_CI_START="-1.564908120195609" LOG_EFFECT_SIZE="-0.6754889084864959" ORDER="7778" O_E="0.0" SE="1.0448984953080735" STUDY_ID="STD-Arvonen-2001" TOTAL_1="18" TOTAL_2="19" VAR="1.091812865497076" WEIGHT="7.275758575807798"/>
<DICH_DATA CI_END="1.5487892172461395" CI_START="0.44837892510590793" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.18999231639329406" LOG_CI_START="-0.34835480848854367" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="7779" O_E="0.0" SE="0.31622776601683794" STUDY_ID="STD-Wilson-1998" TOTAL_1="18" TOTAL_2="15" VAR="0.09999999999999999" WEIGHT="14.683803671175738"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.481427696065847" CI_END="1.2695731687840128" CI_START="-2.494170111019753" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6122984711178702" ESTIMABLE="YES" I2="10.742730413535005" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2013-06-13 16:37:06 +0100" MODIFIED_BY="G Peter Herbison" NO="5" P_CHI2="0.34475547375606275" P_Q="0.9197846448488667" P_Z="0.5236643510511628" Q="0.010141496536758419" RANDOM="NO" SCALE="19.74" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="193" TOTAL_2="192" UNITS="" WEIGHT="99.99999999999999" Z="0.6377071239792604">
<NAME>Pelvic floor muscle strength</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.881680240138344" CI_END="1.708106049436093" CI_START="-2.804762921989832" DF="1" EFFECT_SIZE="-0.5483284362768696" ESTIMABLE="YES" I2="65.2980234909064" ID="CMP-002.05.01" NO="1" P_CHI2="0.0895926210597312" P_Z="0.6338719555775543" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="106" WEIGHT="69.55599022092665" Z="0.4762841525453188">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="9.921933803148978" CI_START="-1.7219338031489793" EFFECT_SIZE="4.1" ESTIMABLE="YES" MEAN_1="-15.1" MEAN_2="-19.2" ORDER="7780" SD_1="11.8" SD_2="10.8" SE="2.970428971691138" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="29" WEIGHT="10.44829602397433"/>
<CONT_DATA CI_END="1.0777552376786672" CI_START="-3.8177552376786674" EFFECT_SIZE="-1.37" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="1.62" ORDER="7781" SD_1="6.42" SD_2="8.94" SE="1.2488776615214607" STUDY_ID="STD-Williams-2006" TOTAL_1="79" TOTAL_2="77" WEIGHT="59.10769419695232"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.589605959390744" CI_END="2.652213062432735" CI_START="-4.169117039787843" DF="2" EFFECT_SIZE="-0.7584519886775539" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" MODIFIED="2013-03-25 01:14:26 +0000" MODIFIED_BY="G Peter Herbison" NO="2" P_CHI2="0.45167038539117443" P_Z="0.6629455186971973" STUDIES="3" TAU2="0.0" TOTAL_1="85" TOTAL_2="86" WEIGHT="30.44400977907334" Z="0.43585006429372686">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="3.64301516760536" CI_START="-5.363015167605359" EFFECT_SIZE="-0.8599999999999994" ESTIMABLE="YES" MEAN_1="-34.98" MEAN_2="-34.12" MODIFIED="2013-03-25 01:14:26 +0000" MODIFIED_BY="G Peter Herbison" ORDER="78" SD_1="13.2" SD_2="9.84" SE="2.2974989352480804" STUDY_ID="STD-Gameiro-2010" TOTAL_1="51" TOTAL_2="52" WEIGHT="17.465184395195177"/>
<CONT_DATA CI_END="4.626654004649858" CI_START="-20.666654004649864" EFFECT_SIZE="-8.020000000000003" ESTIMABLE="YES" MEAN_1="-43.24" MEAN_2="-35.22" MODIFIED="2013-03-15 01:42:13 +0000" MODIFIED_BY="G Peter Herbison" ORDER="77" SD_1="16.28" SD_2="18.96" SE="6.452493058242424" STUDY_ID="STD-Pereira-2012" TOTAL_1="15" TOTAL_2="15" WEIGHT="2.2142605410178895"/>
<CONT_DATA CI_END="6.635770398873832" CI_START="-4.835770398873831" EFFECT_SIZE="0.9000000000000004" ESTIMABLE="YES" MEAN_1="-12.7" MEAN_2="-13.6" ORDER="7782" SD_1="9.6" SD_2="8.4" SE="2.9264672433355186" STUDY_ID="STD-Wilson-1998" TOTAL_1="19" TOTAL_2="19" WEIGHT="10.764564842860276"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-06-13 16:38:09 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>CONES versus ELECTROSTIMULATION</NAME>
<DICH_OUTCOME CHI2="2.814173812224137" CI_END="1.872363107086758" CI_START="0.8523636303267121" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2633028992471567" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="28" I2="28.931184303099883" I2_Q="63.652115011980754" ID="CMP-003.01" LOG_CI_END="0.27239007523125724" LOG_CI_START="-0.06937508956013023" LOG_EFFECT_SIZE="0.10150749283556353" METHOD="MH" MODIFIED="2013-06-13 16:37:16 +0100" MODIFIED_BY="G Peter Herbison" NO="1" P_CHI2="0.2448558294669939" P_Q="0.09718205188638263" P_Z="0.24432040110316067" Q="2.751191713987247" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="72" TOTAL_2="79" WEIGHT="100.0" Z="1.1642557557912685">
<NAME>No subjective improvement or cure after treatment</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.051650964905756935" CI_END="1.6162441031286687" CI_START="0.5840567547671112" DF="1" EFFECT_SIZE="0.9715854495538776" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="19" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.20850695336665523" LOG_CI_START="-0.2335449489756812" LOG_EFFECT_SIZE="-0.012518997804512972" MODIFIED="2013-03-30 00:01:34 +0000" MODIFIED_BY="G Peter Herbison" NO="1" P_CHI2="0.8202149775314724" P_Z="0.9116059270897597" STUDIES="2" TAU2="0.0" TOTAL_1="48" TOTAL_2="49" WEIGHT="70.01441614608362" Z="0.11101313981171161">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="2.108680448592996" CI_START="0.5019456545600034" EFFECT_SIZE="1.02880658436214" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.32401077133379835" LOG_CI_START="-0.29934330118634744" LOG_EFFECT_SIZE="0.012333735073725415" ORDER="7783" O_E="0.0" SE="0.36616126785075737" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.13407407407407407" WEIGHT="35.031234983181164"/>
<DICH_DATA CI_END="1.8821734567289308" CI_START="0.44412398036879075" EFFECT_SIZE="0.9142857142857143" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.27465964450512664" LOG_CI_START="-0.352495776565866" LOG_EFFECT_SIZE="-0.03891806603036967" MODIFIED="2013-03-30 00:01:34 +0000" MODIFIED_BY="G Peter Herbison" ORDER="73" O_E="0.0" SE="0.36839419880650365" STUDY_ID="STD-Santos-2009" TOTAL_1="21" TOTAL_2="24" VAR="0.13571428571428573" WEIGHT="34.983181162902454"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.6977039293661296" CI_START="1.022489704355262" DF="0" EFFECT_SIZE="1.9444444444444444" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.567932134786891" LOG_CI_START="0.009658943707048234" LOG_EFFECT_SIZE="0.28879553924696955" NO="2" P_CHI2="1.0" P_Z="0.042582249179995056" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="30" WEIGHT="29.985583853916385" Z="2.0277844785096697">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="3.6977039293661296" CI_START="1.022489704355262" EFFECT_SIZE="1.9444444444444444" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.567932134786891" LOG_CI_START="0.009658943707048234" LOG_EFFECT_SIZE="0.28879553924696955" ORDER="7784" O_E="0.0" SE="0.3279324359371646" STUDY_ID="STD-Olah-1990" TOTAL_1="24" TOTAL_2="30" VAR="0.10753968253968255" WEIGHT="29.985583853916385"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.18340187467236" CI_END="1.587707866780189" CI_START="0.9756378034702506" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2445994599459944" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="42" I2="82.11635401809619" I2_Q="86.4473560113083" ID="CMP-003.02" LOG_CI_END="0.20077059663223762" LOG_CI_START="-0.010711380231566633" LOG_EFFECT_SIZE="0.0950296082003355" METHOD="MH" MODIFIED="2013-06-13 16:37:23 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.00372868695440165" P_Q="0.0066003624406313355" P_Z="0.07816683425941046" Q="7.378634020301849" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="73" TOTAL_2="81" WEIGHT="99.99999999999999" Z="1.7614230044535562">
<NAME>No subjective improvement or cure after 6 months</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.305230320536159" CI_END="1.2639162710530754" CI_START="0.7531820549626314" DF="1" EFFECT_SIZE="0.9756838905775075" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="33" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.10171830478177431" LOG_CI_START="-0.1231000358719789" LOG_EFFECT_SIZE="-0.010690865545102268" MODIFIED="2013-03-26 23:17:30 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5806220062053867" P_Z="0.852126613486399" STUDIES="2" TAU2="0.0" TOTAL_1="51" TOTAL_2="51" WEIGHT="81.43564356435643" Z="0.18640571201645698">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="1.1663542950265542" CI_START="0.7350586558111525" EFFECT_SIZE="0.9259259259259259" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="22" LOG_CI_END="0.06683049296406621" LOG_CI_START="-0.1336780039379656" LOG_EFFECT_SIZE="-0.0334237554869497" ORDER="7785" O_E="0.0" SE="0.11777968361332049" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.013872053872053876" WEIGHT="55.69306930693069"/>
<DICH_DATA CI_END="2.0239539393627033" CI_START="0.57986058293434" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.3062006247150783" LOG_CI_START="-0.2366764121966545" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2011-02-24 03:10:30 +0000" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.31888865876662453" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="26" VAR="0.1016899766899767" WEIGHT="25.74257425742574"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.432918867055346" CI_START="1.3257520626360275" DF="0" EFFECT_SIZE="2.4242424242424243" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="9" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="0.6466897827514867" LOG_CI_START="0.12246231147662562" LOG_EFFECT_SIZE="0.38457604711405613" NO="2" P_CHI2="1.0" P_Z="0.0040315832861459455" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="30" WEIGHT="18.56435643564356" Z="2.8756799021893418">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="4.432918867055345" CI_START="1.3257520626360277" EFFECT_SIZE="2.4242424242424243" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="9" LOG_CI_END="0.6466897827514866" LOG_CI_START="0.12246231147662569" LOG_EFFECT_SIZE="0.38457604711405613" ORDER="7786" O_E="0.0" SE="0.3079338115946872" STUDY_ID="STD-Olah-1990" TOTAL_1="22" TOTAL_2="30" VAR="0.09482323232323231" WEIGHT="18.56435643564356"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.6268070327900004" CI_END="0.1663365340526589" CI_START="-0.2689875244802635" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.051325495213802294" ESTIMABLE="YES" I2="44.85507549979971" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2013-06-13 16:37:31 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.1630981529700416" P_Q="1.0" P_Z="0.6439618475949072" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="74" TOTAL_2="83" UNITS="" WEIGHT="100.0" Z="0.4621666096137786">
<NAME>Leakage episodes per day</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.6268070327900004" CI_END="0.1663365340526589" CI_START="-0.2689875244802635" DF="2" EFFECT_SIZE="-0.051325495213802294" ESTIMABLE="YES" I2="44.85507549979971" ID="CMP-003.03.01" MODIFIED="2013-03-15 01:28:25 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1630981529700416" P_Z="0.6439618475949072" STUDIES="3" TAU2="0.0" TOTAL_1="74" TOTAL_2="83" WEIGHT="100.0" Z="0.4621666096137786">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="1.3047760768301755" CI_START="-0.10477607683017565" EFFECT_SIZE="0.6" ESTIMABLE="YES" MEAN_1="1.17" MEAN_2="0.57" ORDER="7787" SD_1="1.8" SD_2="0.75" SE="0.35958623851731936" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="32" WEIGHT="9.538125664749685"/>
<CONT_DATA CI_END="0.19561799421247109" CI_START="-0.43561799421247116" EFFECT_SIZE="-0.12000000000000002" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.33" MODIFIED="2011-02-24 03:11:49 +0000" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="0.26" SD_2="0.79" SE="0.16103254789477028" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="27" WEIGHT="47.559998970882255"/>
<CONT_DATA CI_END="0.2123108607641335" CI_START="-0.4523108607641335" EFFECT_SIZE="-0.12000000000000002" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.33" MODIFIED="2013-03-15 01:28:25 +0000" MODIFIED_BY="G Peter Herbison" ORDER="75" SD_1="0.24" SD_2="0.79" SE="0.1695494730440759" STUDY_ID="STD-Santos-2009" TOTAL_1="21" TOTAL_2="24" WEIGHT="42.90187536436806"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.1372697775230638" CI_START="-0.9372697775230641" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2013-06-13 16:37:38 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.8501287756399463" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.1889541204237459">
<NAME>Grams of leakage per day after treatment</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1372697775230638" CI_START="-0.9372697775230641" DF="0" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.01" MODIFIED="2013-05-14 10:07:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8501287756399463" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="30" WEIGHT="100.0" Z="0.1889541204237459">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="1.1372697775230638" CI_START="-0.9372697775230641" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.1" ORDER="7788" SD_1="2.1" SD_2="1.7" SE="0.5292289989535092" STUDY_ID="STD-Olah-1990" TOTAL_1="24" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.49778571604969124" CI_START="-0.8977857160496914" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.20000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2013-06-13 16:37:49 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.5742749681874554" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.5617667256463245">
<NAME>Grams of leakage per day after 6 months</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.49778571604969124" CI_START="-0.8977857160496914" DF="0" EFFECT_SIZE="-0.20000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.01" MODIFIED="2013-05-14 10:07:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5742749681874554" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="30" WEIGHT="100.0" Z="0.5617667256463245">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="0.49778571604969124" CI_START="-0.8977857160496914" EFFECT_SIZE="-0.20000000000000007" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.8" ORDER="7789" SD_1="1.3" SD_2="1.3" SE="0.35601966237835797" STUDY_ID="STD-Olah-1990" TOTAL_1="24" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.6176894022773474" CI_END="1.6257991589905236" CI_START="0.8950865921230737" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2063295688564495" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="47" I2="0.0" I2_Q="64.24992795282708" ID="CMP-003.06" LOG_CI_END="0.2110668945609431" LOG_CI_START="-0.04813494830183923" LOG_EFFECT_SIZE="0.08146597312955196" METHOD="MH" MODIFIED="2013-06-13 16:37:56 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.46021049551806514" P_Q="0.09442934456881247" P_Z="0.21794323312941377" Q="2.797197159995875" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="117" TOTAL_2="126" WEIGHT="99.99999999999999" Z="1.2320157259372326">
<NAME>No improvement on pad test after treatment</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7059579831364129" CI_END="1.4640496171063855" CI_START="0.761896965575844" DF="3" EFFECT_SIZE="1.0561510122732598" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="40" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="0.16555579534967185" LOG_CI_START="-0.11810375609793111" LOG_EFFECT_SIZE="0.02372601962587038" MODIFIED="2013-03-15 01:22:16 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8718017057474472" P_Z="0.7430077435032081" STUDIES="4" TAU2="0.0" TOTAL_1="93" TOTAL_2="96" WEIGHT="86.18038931072384" Z="0.32787292883938884">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="3.3422635842039967" CI_START="0.5771574554430097" EFFECT_SIZE="1.3888888888888888" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5240406970987518" LOG_CI_START="-0.23870568996128874" LOG_EFFECT_SIZE="0.14266750356873154" ORDER="7790" O_E="0.0" SE="0.4480410034145767" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="27" TOTAL_2="25" VAR="0.20074074074074075" WEIGHT="13.83859367099219"/>
<DICH_DATA CI_END="1.7522963725949712" CI_START="0.6227706203394806" EFFECT_SIZE="1.0446428571428572" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.243607561933152" LOG_CI_START="-0.20567188378119194" LOG_EFFECT_SIZE="0.01896783907598006" MODIFIED="2011-02-24 03:14:50 +0000" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.26390897038172967" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="27" VAR="0.06964794464794466" WEIGHT="29.265057930231848"/>
<DICH_DATA CI_END="1.8548378341602363" CI_START="0.5916989877614438" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.2683059458605142" LOG_CI_START="-0.2278991736839402" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2013-03-15 01:22:16 +0000" MODIFIED_BY="G Peter Herbison" ORDER="74" O_E="0.0" SE="0.29147334347536824" STUDY_ID="STD-Santos-2009" TOTAL_1="21" TOTAL_2="24" VAR="0.08495670995670998" WEIGHT="24.875299240697068"/>
<DICH_DATA CI_END="1.8707847669884377" CI_START="0.37120488508271915" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.27202382497401284" LOG_CI_START="-0.43038631706926245" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="7791" O_E="0.0" SE="0.41259919442249915" STUDY_ID="STD-Wise-1993" TOTAL_1="21" TOTAL_2="20" VAR="0.17023809523809524" WEIGHT="18.201438468802735"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.591639505739781" CI_START="1.000042953928297" DF="0" EFFECT_SIZE="2.142857142857143" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" ID="CMP-003.06.02" LOG_CI_END="0.6619677838294471" LOG_CI_START="1.8654253401546465E-5" LOG_EFFECT_SIZE="0.3309932190414244" NO="2" P_CHI2="1.0" P_Z="0.049987088932799004" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="30" WEIGHT="13.81961068927615" Z="1.9600744512305956">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="4.591639505739781" CI_START="1.0000429539282971" EFFECT_SIZE="2.142857142857143" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="0.6619677838294471" LOG_CI_START="1.865425340164289E-5" LOG_EFFECT_SIZE="0.3309932190414244" ORDER="7792" O_E="0.0" SE="0.38883219541400654" STUDY_ID="STD-Olah-1990" TOTAL_1="24" TOTAL_2="30" VAR="0.15119047619047618" WEIGHT="13.81961068927615"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7602562470821717" CI_END="1.8881354729176105" CI_START="0.7962711688498939" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.226159793814433" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="0.2760331515244532" LOG_CI_START="-0.09893900879475152" LOG_EFFECT_SIZE="0.08854707136485085" METHOD="MH" MODIFIED="2013-06-13 16:38:03 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.38324837873633066" P_Q="0.3903077841176268" P_Z="0.35462075521024794" Q="0.7379830223716034" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="57" WEIGHT="100.0" Z="0.9256637648185267">
<NAME>No improvement on pad test at 6 months</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.7522963725949712" CI_START="0.6227706203394807" DF="0" EFFECT_SIZE="1.0446428571428572" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" I2="0.0" ID="CMP-003.07.01" LOG_CI_END="0.243607561933152" LOG_CI_START="-0.20567188378119186" LOG_EFFECT_SIZE="0.01896783907598006" MODIFIED="2011-02-24 03:16:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8685560298971892" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="27" WEIGHT="64.94845360824742" Z="0.1654929100723181">
<NAME>Urodynamically proven stress incontinence</NAME>
<DICH_DATA CI_END="1.7522963725949712" CI_START="0.6227706203394806" EFFECT_SIZE="1.0446428571428572" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.243607561933152" LOG_CI_START="-0.20567188378119194" LOG_EFFECT_SIZE="0.01896783907598006" MODIFIED="2011-02-24 03:16:42 +0000" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.26390897038172967" STUDY_ID="STD-Castro-2008" TOTAL_1="24" TOTAL_2="27" VAR="0.06964794464794466" WEIGHT="64.94845360824742"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.3380202434217074" CI_START="0.7313934823526971" DF="0" EFFECT_SIZE="1.5625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-003.07.02" LOG_CI_END="0.5234889661298319" LOG_CI_START="-0.13584891409760616" LOG_EFFECT_SIZE="0.19382002601611284" NO="2" P_CHI2="1.0" P_Z="0.24919440900619916" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="30" WEIGHT="35.051546391752574" Z="1.1523083440713526">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="3.3380202434217074" CI_START="0.7313934823526971" EFFECT_SIZE="1.5625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.5234889661298319" LOG_CI_START="-0.13584891409760616" LOG_EFFECT_SIZE="0.19382002601611284" ORDER="7793" O_E="0.0" SE="0.3872983346207417" STUDY_ID="STD-Olah-1990" TOTAL_1="24" TOTAL_2="30" VAR="0.15000000000000002" WEIGHT="35.051546391752574"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="10.322446235221019" CI_START="-3.3224462352210153" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.5000000000000018" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2013-06-13 16:38:09 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.3146629172160609" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="29" TOTAL_2="32" UNITS="" WEIGHT="100.0" Z="1.005485966379032">
<NAME>Pelvic floor muscle strength</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="10.322446235221019" CI_START="-3.3224462352210153" DF="0" EFFECT_SIZE="3.5000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-003.08.01" NO="1" P_CHI2="1.0" P_Z="0.3146629172160609" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="32" WEIGHT="100.0" Z="1.005485966379032">
<NAME>Urodynamically-proven stress incontinence</NAME>
<CONT_DATA CI_END="10.322446235221019" CI_START="-3.3224462352210153" EFFECT_SIZE="3.5000000000000018" ESTIMABLE="YES" MEAN_1="-15.1" MEAN_2="-18.6" ORDER="7794" SD_1="11.8" SD_2="15.3" SE="3.4809038783547055" STUDY_ID="STD-B_x00f8_-1999" TOTAL_1="29" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-06-13 16:38:49 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>CONES + PELVIC FLOOR MUSCLE TRAINING versus PELVIC FLOOR MUSCLE TRAINING</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.451026510576237" CI_START="0.8075971051171871" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.406926406926407" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.389348008655059" LOG_CI_START="-0.09280524648159882" LOG_EFFECT_SIZE="0.14827138108673008" METHOD="MH" MODIFIED="2013-06-13 16:38:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.2280284570562957" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="25" WEIGHT="100.0" Z="1.2054530951393745">
<NAME>No subjective improvement or cure after 6 weeks</NAME>
<GROUP_LABEL_1>Cones + PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.451026510576237" CI_START="0.8075971051171871" DF="0" EFFECT_SIZE="1.406926406926407" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.389348008655059" LOG_CI_START="-0.09280524648159882" LOG_EFFECT_SIZE="0.14827138108673008" NO="1" P_CHI2="1.0" P_Z="0.2280284570562957" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="25" WEIGHT="100.0" Z="1.2054530951393745">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="2.451026510576237" CI_START="0.8075971051171872" EFFECT_SIZE="1.406926406926407" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="11" LOG_CI_END="0.389348008655059" LOG_CI_START="-0.09280524648159875" LOG_EFFECT_SIZE="0.14827138108673008" ORDER="7795" O_E="0.0" SE="0.2832192087643778" STUDY_ID="STD-Pieber-1995" TOTAL_1="21" TOTAL_2="25" VAR="0.08021312021312021" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6449342984860722" CI_START="0.5098074375800008" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9157509157509157" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.21614855616150153" LOG_CI_START="-0.2925938328989385" LOG_EFFECT_SIZE="-0.03822263836871844" METHOD="MH" MODIFIED="2013-06-13 16:38:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.768367820811816" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="25" WEIGHT="100.0" Z="0.29451052716539744">
<NAME>No subjective improvement or cure after 12 weeks</NAME>
<GROUP_LABEL_1>Cones + PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6449342984860722" CI_START="0.5098074375800008" DF="0" EFFECT_SIZE="0.9157509157509157" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="0.21614855616150153" LOG_CI_START="-0.2925938328989385" LOG_EFFECT_SIZE="-0.03822263836871844" NO="1" P_CHI2="1.0" P_Z="0.768367820811816" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="25" WEIGHT="100.0" Z="0.29451052716539744">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="1.6449342984860722" CI_START="0.5098074375800008" EFFECT_SIZE="0.9157509157509157" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" LOG_CI_END="0.21614855616150153" LOG_CI_START="-0.2925938328989385" LOG_EFFECT_SIZE="-0.03822263836871844" ORDER="7796" O_E="0.0" SE="0.29883779764954316" STUDY_ID="STD-Pieber-1995" TOTAL_1="21" TOTAL_2="25" VAR="0.08930402930402931" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3249004728376903" CI_START="0.6259529922513626" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2063492063492063" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.3664043658184148" LOG_CI_START="-0.2034582801639955" LOG_EFFECT_SIZE="0.08147304282720962" METHOD="MH" MODIFIED="2013-06-13 16:38:35 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.5751857734235202" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="19" WEIGHT="100.0" Z="0.5604305906976369">
<NAME>No subjective cure</NAME>
<GROUP_LABEL_1>Cones + PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3249004728376903" CI_START="0.6259529922513626" DF="0" EFFECT_SIZE="1.2063492063492063" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.3664043658184148" LOG_CI_START="-0.2034582801639955" LOG_EFFECT_SIZE="0.08147304282720962" MODIFIED="2013-05-14 10:08:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5751857734235202" STUDIES="1" TAU2="0.0" TOTAL_1="14" TOTAL_2="19" WEIGHT="100.0" Z="0.5604305906976369">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="2.3249004728376903" CI_START="0.6259529922513626" EFFECT_SIZE="1.2063492063492063" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.3664043658184148" LOG_CI_START="-0.2034582801639955" LOG_EFFECT_SIZE="0.08147304282720962" ORDER="7797" O_E="0.0" SE="0.33474013911565975" STUDY_ID="STD-Wilson-1998" TOTAL_1="14" TOTAL_2="19" VAR="0.11205096073517126" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.8940485279071684" CI_START="0.45264881425667636" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9259259259259259" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.2773911019810403" LOG_CI_START="-0.34423861295493974" LOG_EFFECT_SIZE="-0.0334237554869497" METHOD="MH" MODIFIED="2013-06-13 16:38:43 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.8330694872920473" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="15" WEIGHT="100.0" Z="0.21076649139670253">
<NAME>No improvement on pad test</NAME>
<GROUP_LABEL_1>Cones + PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8940485279071684" CI_START="0.45264881425667636" DF="0" EFFECT_SIZE="0.9259259259259259" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="0.2773911019810403" LOG_CI_START="-0.34423861295493974" LOG_EFFECT_SIZE="-0.0334237554869497" MODIFIED="2013-05-14 10:08:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8330694872920473" STUDIES="1" TAU2="0.0" TOTAL_1="9" TOTAL_2="15" WEIGHT="100.0" Z="0.21076649139670253">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.8940485279071686" CI_START="0.45264881425667636" EFFECT_SIZE="0.9259259259259259" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.27739110198104033" LOG_CI_START="-0.34423861295493974" LOG_EFFECT_SIZE="-0.0334237554869497" ORDER="7798" O_E="0.0" SE="0.36514837167011077" STUDY_ID="STD-Wilson-1998" TOTAL_1="9" TOTAL_2="15" VAR="0.13333333333333336" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.780712611750107" CI_START="-5.580712611750108" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2013-06-13 16:38:49 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.8491008314156157" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="19" UNITS="" WEIGHT="100.0" Z="0.19026582606160783">
<NAME>Pelvic floor muscle strength</NAME>
<GROUP_LABEL_1>Cones + PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.780712611750107" CI_START="-5.580712611750108" DF="0" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-004.05.01" MODIFIED="2013-05-14 10:08:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8491008314156157" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="19" WEIGHT="100.0" Z="0.19026582606160783">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="6.780712611750107" CI_START="-5.580712611750108" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-13.6" ORDER="7799" SD_1="9.0" SD_2="8.4" SE="3.1534827478988285" STUDY_ID="STD-Wilson-1998" TOTAL_1="13" TOTAL_2="19" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-06-26 12:02:05 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>CONES + PELVIC FLOOR MUSCLE TRAINING versus ELECTROSTIMULATION</NAME>
<DICH_OUTCOME CHI2="0.013117524916511056" CI_END="2.608740883642441" CI_START="0.8198444506472223" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.4624505928853755" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.4164309444153597" LOG_CI_START="-0.08626853863300556" LOG_EFFECT_SIZE="0.1650812028911771" METHOD="MH" MODIFIED="2013-06-13 16:41:59 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9088162701518128" P_Q="1.0" P_Z="0.19800264925199682" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="77" TOTAL_2="83" WEIGHT="100.0" Z="1.2872629596880933">
<NAME>No subjective improvement or cure after treatment</NAME>
<GROUP_LABEL_1>Cones plus PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.869564171556653" CI_START="0.7875114359250834" EFFECT_SIZE="1.5032679738562091" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.45781594124235275" LOG_CI_START="-0.10374313084236464" LOG_EFFECT_SIZE="0.17703640519999408" ORDER="7800" O_E="0.0" SE="0.32986257870480123" STUDY_ID="STD-Laycock-1993" TOTAL_1="17" TOTAL_2="23" VAR="0.1088093208297812" WEIGHT="60.47430830039526"/>
<DICH_DATA CI_END="4.1657466796913445" CI_START="0.47050388578722313" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6196928568366007" LOG_CI_START="-0.32743678548012456" LOG_EFFECT_SIZE="0.146128035678238" ORDER="7801" O_E="0.0" SE="0.5563486402641868" STUDY_ID="STD-Seo-2004" TOTAL_1="60" TOTAL_2="60" VAR="0.30952380952380953" WEIGHT="39.52569169960474"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="2.2602600814324526E-30" CI_END="0.4923684244603934" CI_START="0.3476315755396068" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.4200000000000001" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2013-06-26 12:02:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="5.5755416042045015E-30" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" UNITS="" WEIGHT="99.99999999999999" Z="11.374917716459965">
<NAME>Changes in leakage episodes per day</NAME>
<GROUP_LABEL_1>Cones plus PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4923684244603934" CI_START="0.34763157553960666" EFFECT_SIZE="0.42000000000000004" ESTIMABLE="YES" MEAN_1="-0.63" MEAN_2="-1.05" ORDER="7802" SD_1="0.23" SD_2="0.17" SE="0.03692334401612797" STUDY_ID="STD-Seo-2004" TOTAL_1="60" TOTAL_2="60" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.06311757508564236" CI_END="1.2974498257535942" CI_START="0.4607138227386793" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7731449211076612" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="0.11309057205446446" LOG_CI_START="-0.336568757469316" LOG_EFFECT_SIZE="-0.11173909270742581" METHOD="MH" MODIFIED="2013-06-13 16:42:33 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8016346605210872" P_Q="1.0" P_Z="0.33001127224802895" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="43" WEIGHT="100.0" Z="0.9740911974568722">
<NAME>No improvement on pad test</NAME>
<GROUP_LABEL_1>Cones plus PFMT</GROUP_LABEL_1>
<GROUP_LABEL_2>Electrostimulation</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones+PFMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours electro-stim</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4262117425977547" CI_START="0.3721201581328045" EFFECT_SIZE="0.7285067873303167" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.1541840078546467" LOG_CI_START="-0.42931680316116877" LOG_EFFECT_SIZE="-0.137566397653261" ORDER="7803" O_E="0.0" SE="0.3427512647662877" STUDY_ID="STD-Laycock-1993" TOTAL_1="17" TOTAL_2="23" VAR="0.11747842949888984" WEIGHT="57.41714720233192"/>
<DICH_DATA CI_END="1.8707847669884377" CI_START="0.37120488508271915" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.27202382497401284" LOG_CI_START="-0.43038631706926245" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="7804" O_E="0.0" SE="0.41259919442249915" STUDY_ID="STD-Wise-1993" TOTAL_1="21" TOTAL_2="20" VAR="0.17023809523809524" WEIGHT="42.582852797668075"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-06-13 16:43:06 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>CONES versus PELVIC FLOOR MUSCLE TRAINING + CONES</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.577203174548703" CI_START="0.44030119622549657" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.19788764253737423" LOG_CI_START="-0.3562501346326238" LOG_EFFECT_SIZE="-0.0791812460476248" METHOD="MH" MODIFIED="2013-06-13 16:42:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5753962021328578" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="14" WEIGHT="100.00000000000001" Z="0.5601220378690743">
<NAME>No subjective cure</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT + cones</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT+cones</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.577203174548703" CI_START="0.44030119622549657" DF="0" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-006.01.01" LOG_CI_END="0.19788764253737423" LOG_CI_START="-0.3562501346326238" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2013-05-14 10:07:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5753962021328578" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="14" WEIGHT="100.00000000000001" Z="0.5601220378690743">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.577203174548703" CI_START="0.4403011962254965" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.19788764253737423" LOG_CI_START="-0.35625013463262384" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="7805" O_E="0.0" SE="0.32550327333589285" STUDY_ID="STD-Wilson-1998" TOTAL_1="21" TOTAL_2="14" VAR="0.10595238095238096" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.034340238472892776" CI_END="1.6847059164376055" CI_START="0.5370780452258455" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9512195121951219" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="0.22652410104411125" LOG_CI_START="-0.26996260043058384" LOG_EFFECT_SIZE="-0.021719249693236308" METHOD="MH" MODIFIED="2013-06-13 16:42:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8529850151300706" P_Q="0.8555381906606074" P_Z="0.8638457934538195" Q="0.03314468295545186" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="30" WEIGHT="100.0" Z="0.1714807145630886">
<NAME>No improvement on pad test</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT + cones</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT+cones</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.3523113813179237" CI_START="0.4251137872060681" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" I2="0.0" ID="CMP-006.02.01" LOG_CI_END="0.37149480985193356" LOG_CI_START="-0.37149480985193356" LOG_EFFECT_SIZE="0.0" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="21" WEIGHT="51.21951219512195" Z="0.0">
<NAME>Urodynamically-proven stress incontinence</NAME>
<DICH_DATA CI_END="2.3523113813179233" CI_START="0.4251137872060682" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.37149480985193345" LOG_CI_START="-0.3714948098519335" LOG_EFFECT_SIZE="0.0" ORDER="7806" O_E="0.0" SE="0.4364357804719847" STUDY_ID="STD-Wise-1993" TOTAL_1="21" TOTAL_2="21" VAR="0.19047619047619047" WEIGHT="51.21951219512195"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0800022534294578E-31" CI_END="1.8956094710381142" CI_START="0.4273032037323649" DF="0" EFFECT_SIZE="0.8999999999999999" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" I2="100.0" ID="CMP-006.02.02" LOG_CI_END="0.27774886989933834" LOG_CI_START="-0.3692638510206887" LOG_EFFECT_SIZE="-0.04575749056067517" NO="2" P_CHI2="0.0" P_Z="0.781609759081696" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="9" WEIGHT="48.78048780487805" Z="0.27722185552806144">
<NAME>Symptoms of incontinence</NAME>
<DICH_DATA CI_END="1.8956094710381146" CI_START="0.427303203732365" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.27774886989933845" LOG_CI_START="-0.3692638510206886" LOG_EFFECT_SIZE="-0.045757490560675115" ORDER="7807" O_E="0.0" SE="0.38005847503304596" STUDY_ID="STD-Wilson-1998" TOTAL_1="18" TOTAL_2="9" VAR="0.14444444444444443" WEIGHT="48.78048780487805"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.82444177857742" CI_START="-6.224441778577418" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2013-06-13 16:43:06 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.9281910642386292" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="13" UNITS="" WEIGHT="99.99999999999999" Z="0.0901209966027503">
<NAME>Pelvic floor muscle strength</NAME>
<GROUP_LABEL_1>Cones</GROUP_LABEL_1>
<GROUP_LABEL_2>PFMT + cones</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours cones</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PFMT+cones</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.82444177857742" CI_START="-6.224441778577418" DF="0" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" I2="0.0" ID="CMP-006.03.01" MODIFIED="2013-05-14 10:07:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9281910642386292" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="13" WEIGHT="99.99999999999999" Z="0.0901209966027503">
<NAME>Symptoms of incontinence</NAME>
<CONT_DATA CI_END="6.82444177857742" CI_START="-6.224441778577418" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="-12.7" MEAN_2="-13.0" ORDER="7808" SD_1="9.6" SD_2="9.0" SE="3.328857994351622" STUDY_ID="STD-Wilson-1998" TOTAL_1="19" TOTAL_2="13" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-07-08 11:17:28 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-06-04 11:42:07 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAN6CAYAAACkCs88AABct0lEQVR42u2dD4SVy//Hv1xJkiwr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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-07-08 11:17:28 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtQAAAEACAMAAACktBFmAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-07-08 11:17:28 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAToAAAR9CAIAAABJRRx4AAA4gklEQVR42u3dvY4dxdbG8ZGQEMEE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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;23 reports of 16 studies were included in the quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;34 reports of 23 studies were included in the qualitative synthesis, plus there was one ongoing study (&lt;a link_type=&quot;STUDY&quot; protected=&quot;true&quot; href=&quot;Driusso 2010&quot;&gt;Driusso 2010&lt;/a&gt;).&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;43 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;56 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;56 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;56 records identified through searching the Specialised Register&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;13 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;8 full-text articles excluded, with reasons given in the &lt;a link_type=&quot;SECTION&quot; protected=&quot;true&quot; href=&quot;CHARACTERISTICS_OF_EXCLUDED_STUDIES&quot;&gt;Characteristics of excluded studies&lt;/a&gt; table.&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>